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Abstract
Chronic low back pain costs the community, and several authors have suggested that
individuals often attempt to exaggerate chronic low back pain. Currently no reliable
and valid scale for assessing malingering in chronic pain populations exists, and there is
a large difference in opinion on the ability of experts using clinical judgment to detect
malingering. The current study seeks to provide a validation for the BarkemeyerCallon-Jones Malingering Detection Scale (MDS) which has purported to be able to
identify individuals attempting to malinger neurological conditions and pain. A
simulation design was used, as in previous research, because it is difficult to identify
actual malingerers in a known groups design. Thirty-two men with chronic low back
pain were divided into two groups of sixteen. One group was asked to simulate
malingering for the purposes of gaining an increased compensation while the other
group is asked to be as honest as possible. The hypotheses tested were whether the
responses to the MDS can: discriminate between simulating malingerers and controls,
show an increased focus on severity rather than description of pain by simulating
malingerers, show a relationship between malingering scores and reported pain levels,
show that prior litigation contributes to either MDS scores or reported pain levels.
Significance was assessed using chi square, !-test, bivariate correlation and two
ANOVAs. While the MDS was able to discriminate to a significant level between
participants asked to malinger and those being honest, methodological issues suggest
that levels of pre-assessment injury contribute to malingering scores and that conscious
intent is what separates malingering from psychological disorders (abnormal illness
behaviour) is context bound. Litigation has no effect on reported pain level or MDS
scores.
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Introduction

Pain costs the community. lt was recently estimated that pain cost the Australian
community 15 billion dollars in direct and indirect costs (Pain Drain, 1997).
The purpose of the current research is to validate a structured interview tool, the
Barkemeyer-Callon-Jones Malingering Detection Scale (1989) (MDS) (See Appendix 1),
which purports to detect individuals attempting to malinger for pain and neurological
conditions. If successful the scale could be.used to recoup some of this loss to Australia
for chronic pain. However, prior to using this scale as part of legal proceedings there
needs to be significantly more experimental assessment of this instrument. Specifically,
the very small research base of this instrument means that currently it could not be used
under the Daubert rules (Daubert v Merrell Dow Pharmaceuticals, 1993) of scientific
validity in the court room. Australian courts, while not directly following this precedent,
adhere to many of the concepts of expert evidence founded by this decision. In fact,
other than validation procedures completed by the authors of the scale, this scale has only
been cited on four occasions (Dannebaum & Lanyon, 1993; Cunnien, 1997; Smith, 1997;
Hall & Pritchard, 1996).

The conditions that will be assessed for use with the MDS are simulated malingering,
chronic low back pain and the effect of previous litigation. The difference between this
method and previous methods of validating malingering scales is that all participants will
have the knowledge (all participants have suffered from chronic low back pain some time
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in their life) to successfully malinger. First, an examination will be made of the different
issues in assessing chronic low back pain that encompass the high level of suspicion
towards this problem in regards to malingering. Second, an analysis will be conducted on
the different issues involved in malingering and malingering research, especially in
regard to pain disorders. Third, an analysis of the methods of assessing malingering will
be completed, and their applicability to the current study discussed. Fourth, the impact of
previous litigation will be examined in regard to both reported back pain and
malingering. Finally, the methodological issues in the validation study (Calion, Jones,
Barkemeyer & Brantley, 1989) already completed will be examined, then the purpose of
the current study, its limitations and hypotheses as generated by the previous research
will discussed.

Issues involved in Chronic Low Back Pain (CLBP)

This section explores the rationale behind pain assessment and demonstrates the need for
an effective means of measuring both chronic pain and malingering. This section is
broken into two subsections. The first looks at the issues pertaining generally to chronic
low back pain, while the second focuses on specific issues in back pain assessment.
Several issues are canvassed in the first section: the definition of chronic pain; the
importance of focusing on only one form of chronic pain (lower back); the cost of chronic
low back pain; yearly prevalence rates of chronic low back pain; difficulty of relying on
objective imaging measures to reliably assess pathology of lower back and the incidence
of malingering in chronic low back pain populations. The second part addresses the
specific issues of: gender differences in pain assessment, reliance on objective tests

r
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(imaging) is limited by the technology, differences between chronic low back pain
patients and general community, pain assessment tools, effect of background of the
patient, the subjectivity of the pain experience, the range of possible external goals for
individuals with chronic low back pain and the application of the Barkemeyer Calion
Jones Malingering Detection Scale within pain settings.

Definition of chronic pain
There are two elements to this definition. Firstly, the definition of chronic is currently
defined by the WorkCover Authority of Western Australia as three months for low back
pain, as most back pain injuries are resolved in two months. However, both the DSM IV
and Turk and Melzack (1992) have suggested that the definition of chronic pain is six
months. This will not affect the current study, however it is important to recognise the
differences in label during the transition from acute to chronic. Secondly, pain has been
defined as "an unpleasant sensory and emotional experience associated with actual or
potential tissue damage, or described in terms of such damage" (International Association
for the Study of Pain, 1979, 249). It is generally accepted that the definition of lower
back is the lumbar spine and most back pain is centred in this area (Waddell & Turk,
1992). Haldeman (1996) noted that "many of the assumptions made for acute back pain
e.g. a direct correlation between symptamology, disability, and pathology- seem to
breakdown when dealing with the patient in chronic pain" (p. 112).

Comparison of'difl'erent pain conditions in research
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Research involving pain assessment has often included different causes of pain (Turk &
Melzack, 1992). For instance myofascial syndrome may be compared with whiplash
injury. The issue is that the quality and quantity of different pain can vary substantially,
yet it is often evaluated as simply representing a general level of pain. Melzack and
Dubissson ( 1976), when evaluating the McGill Pain Questionnaire for discriminative
ability with different clinical pain syndromes, found that it could distinguish between the
syndromes. In fact, through the clustering of verbal pain descriptors in the questionnaire
the type of pain syndrome could be determined with 77% accuracy on the basis of eight
diagnostic categories. Looking at this result in an assessment context suggests that the
type of pain will influence the assessment procedure. The fact that verbal descriptors are
used in structured interview settings, similar to the current study, suggests the need to
limit the assessment of any new instrument to only one pain syndrome. It is interesting to
note that in their widely cited book on pain assessment Melzack and Turk (1992)
included individual chapters for assessing chronic back pain, orofacial pain, myofascial
pain, headaches and cancer pain.

Decision to focus on only those with chronic low back pain
The decision to focus only on chronic low back pain was made for a number of reasons.
The first is that when validating a pain assessment tool, or tools that measure issues
relating to that pain, as the current study is doing, it is important to focus on one pain
syndrome at a time. Each syndrome has different effects and meanings for sufferers
hence the decision to largely separate ditierent pain syndromes by Ronald Melzack and
Dennis when editing, arguably the seminal book in the area, Handbook of Pain
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Early research by Melzack and Dubuisson (1976), already discussed,

clearly supports this approach. Second, is the staggering cost and effect that back pain,
and particularly chronic back pain has on our society. Finally, Leavitt (1984) has
suggested that due to its complexity chronic low back pain is the most likely syndrome to
be malingered. For these reasons chronic low back pain was selected as the most
appropriate syndrome to be assessed in this validation of the Barkemeyer Calion Jones
Malingering Detection Scale.

Costs o( chronic low back pain

The Work Cover Authority of Western Australia has estimated that chronic low back pain
cost the state $105 million in the 91/92 period, $112 million in the 94/95 period and $81
million in the 96/97 period (WorkCover, 1998). In America, chronic pain affects 11
million people and costs $100 billion a year with 80% of this figure due to unexpected
traumatic injuries (Weintraub, 1995). Of this figure, a significant proportion relates to
chronic low back pain. Cats-Baril and Froymeyer (as cited in Haldeman, 1996) have
suggested that the treatment of spinal disorder by 1990, in America, cost approximately
23.5 billion dollars but Leavitt (1985) has suggested that as many as 10% of people with
chronic low back pain may be malingering. If this is the case then a significant amount
of money, time of medical personnel, and drugs could be saved if those who do not suffer
from genuine pain can be identified.

Yearly prevalence rates

Each year some 15%-20% of the population experience/report back pain (Andrews as
cited in Haldeman, 1996) and surveys of working people show that 50% of this group
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report some symptoms of back pain at some point in their career (Sternbach as cited in
Haldeman, 1996). Back pain affects up to 80% of the population at some time during
adult life (Murtagh as cited in Giles & Crawford, 1997). Back pain remains the most
common cause of disability for persons under the age of 45 years (Cunningham & Kelsey
as cited in Haldeman, 1996). In Western Australia it is second only to the common cold
for work absences (WorkCover, 1998) and this is similar to American trends (Deyo &
Tsui-Wu as cited in Giles & Crawford, 1997). Haldeman states that "despite the
advances in understanding and the proliferation of diagnostic tests and treatment
methods, there is still no evidence that there has been any decrease in the frequency or
severity of neck and back pain"(l996, p. 103). This may be the reason that Giles and
Crawford note that "the epidemic increase of sickness in the low back pain syndromes is
actually threatening the social welfare system in societies with socialized medicine"
(1997, p. 44).

Differences between chronic low hack pain patients and general community

The decision to use chronic low back pain sufferers in both the experimental and control
groups appears to have been supported by research. Specifically it has been shown that
chronic pain patients view and react to pain differently from healthy participants and
other those with other pain conditions. It would not be productive to ask healthy controls
to malinger as previous studies have done (Leavitt, 1985; Clayer, Bookless & Ross,
1984) as they often have very little appreciation of the effects of chronic conditions.
Peters and Schmidt (1991) measured pain perception threshold, maximal pain tolerance
and pain discrimination between chronic low back pain patients and healthy controls.
This was done by giving electric shocks to both groups and using forced choice answers

Validation of the MDS

7

for participants to indicate which shock hurt the most and how quickly they perceive it.
All participants completed a state-trait anxiety test prior to the experiment with chronic
low back pain patients showing higher levels of anxiety. The results indicated that
chronic low back pain patients are generally less sensitive to experimental pain than
healthy controls; not only for pain perception threshold but also for pain tolerance, but are
both more anxious about imminent pain and are generally have more anxiety than those
who do not suffer from chronic low back pain.

Two theories were put forward by Peters and Schmidt (1991) to explain this result. The
first is the adaptation level theory (Naliboff & Cohen as cited in Peters & Schmidt, 1991)
which states that chronic pain patients are less inclined to label a stimulus as painful and
would not consider experimental pain as severe because of their extensive experience
with pain. The second theory is that pain inhibits pain due to the activation of the diffuse
noxious inhibitory controls (DNIC) (Roby-Brami, Busse!, Willer & LeBars as cited in
Peters & Schmidt, 1991 ). This suggests that when two concurrent pains occur the body
decides to reduce sensitivity to one of these sensations of pain. In addition to
physiological issues, Kames, Naliboff, Heinrich and Schag (as cited in Fishbain, Cutler,
Rosomoff & Rosomoff, 1994) demonstrated that chronic pain patients have greater issues
than chronic illness patients in areas such as sleep, finances, appearance, body
deterioration, inactivity, social activities, family/friends contact, assertion, medical
interaction and marital difficulty. Waddell and Turk (1992) noted that chronic low back
pain can severely impact on the levels of depression, avoidance of any movement likely
to cause pain and a resulting problem with mobility; more than do most other chronic
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pain conditions. This appears to be a relatively consistent result in Turk and Melzack
(1992), Cherkin, Deyo, Wheeler and Ciol (1995) and Haldeman (1996) with comments
from many of the participants in the current study supporting this premise about the
global issues associated with chronic low back pain. Mendelson (1984a) found that those
experiencing chronic low back pain had significant elevations of depression, neuroticism,
state anxiety and trait anxiety when compared to the normal population. Overall, these
results suggest that individuals who suffer from chronic low back pain are in the best
position to malinger this disorder due to the specificity of symptoms and the fact that they
present much differently to healthy participants.

Issues in pain assessment that impact on the present study
Gender differences in pain assessment
In a similar area, the differences in male and female perception of pain has received
surprisingly little scrutiny (Turk & Melzack, 1992). While some results show males have
a higher tolerance to pain than females (Feine, Bushnell, Miron & Duncan as cited in
Craig, Prkachin & Grunanu, 1992) others research have found the reverse (Craig, Hyde &
Patrick as cited in Craig ct a!., 1992). Hargraves (1996) found that men have higher pain
thresholds than women for acute pain. Overall, these results suggest that rather than
introduce possible gender differences into the reporting of pain, females could be
assessed in later validation studies. ln regards to malingering, little is known about the
different methods the different genders use to malinger (Hall & Pritchard, 1996),
although Leavitt (1991) suggests that there are no differences. This will not be assessed
as part of this study.
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Reliance on objective tests (imaging) is limited by the technology
Barkemeyer et al. (1989) notes that if the patient has a demonstrable injury then
immediately he/she should not be considered a malingerer. The MDS does not need to be
used. Part of the difficulty with back pain, in general, is the complexity of the spine's
relationship with the nervous system. As Giles and Crawford (1997) note "pain may
originate from different spinal tissues such as muscles, ligaments, dura mater,
intervertebral discs, zygapophysial (facet) joint, and other spinal related joints such as
sacroiliac joints" (Giles & Crawford, 1997, 44). In an analysis of 900 patients referred to
an outpatient othropedic clinic Waddell (1982) suggested that based on clinical history
patients could be divided into three broad diagnostic groups: 1) those with simple
mechanical low back pain, 2) those with nerve root pain and 3) those with serious spinal
pathology. Giles and Crawford ( 1997) note that back pain of mechanical origin is far
more prevalent than back pain due to traumatic, inflammatory or other pathological
processes. The latter represent only approximately 19% of cases (Ghormley, 1958 as
cited in Giles & Crawford, 1997). Regardless of type of injury Resnick (1994) suggests
that all people are ready to use illness for their own purposes. Malingering may involve,
not the fact that pain exists but rather whether it was an injury sustained where a duty of
care is owed or an individual is covered by a form of insurance. An evaluation of such
deception, certainly should accompany any evaluation of a personal injury claim, but it
will not be the focus of this study. Similarly, the type of injury the participants sustained
will not be categorised other than whether they have experienced chronic low back pain
at some point.
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Specifically, Giles and Crawford (1997) suggest that when evaluating a patient with
spinal pain of mechanical origin, multifactorial etiologies are possible but an inability to
directly scrutinise the painful structures makes this difficult. As a result of this
uncertainty, a tentative diagnosis is made on the basis of a precise case history, a routine
physical examination, and the use of imaging or laboratory procedures. All this
information generally indicates is that pathology can be eliminated. The actual cause of
the pain remains obscure. Giles and Crawford (1997) suggest that
diagnostic problems relate to 1) inadequacies in the precise anatomical
knowledge of the spine, 2) the possibility of multiple causes of pain at a given
level of the spine, and 3) limitations of the diagnostic yield of many imaging
procedures such as plain film radiography, myleography, computerized
tomography CT), magnetic resonance imaging (MRI) and bone scans (p. 45).
Certainly, there have been significant improvements in the resolution in spinal imaging
(Deyo as cited in Giles & Crawford, 1997) however small abnormalities can still remain
undetected. This has lead to the conclusion that despite
multidisciplinary interest, it is still only rarely possible to validate a diagnosis in
cases where the pain arises from the spine and, because it is not possible to
establish the pathological basis of back pain in 80%-85% of cases this leads to
uncertainty and suspicion (towards) some patients
(Giles & Crawford, J 997, p. 45).

The imaging techniques used are not applicable to all cases of back pain and, even at the
most sophisticated level of MRJ, have problems detecting soft tissue pathology.
Sometimes using plain film radiography there is a discrepancy between the degree of pain
and the severity and radiographic changes (Stockwell as cited in Giles & Crawford,
1997). Finally, Giles and Crawford (1997) state that "it is imperative that, in the absence
of a compelling reason to do so, physicians do not label patients as neurotic or
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malingering when it is not possible to demonstrate objectively through imaging that they
are, in fact, not fabricating symptoms" (p, 47).

Possil>le external goals for iudividllafs with chronic low back pain
It is possible to be awarded damages or benefits through the no-fault workers'

compensation systems or through common law claims for negligence. This can lead to
abuse by individuals or groups. Workers' compensation systems are particularly
vulnerable as low back pain is the most common type of compensated injury
(WorkCover, 1998). Chaffin's (as cited in Waikar, Aghazadeh & Schlegel, 1991)
findings indicate the type of work that is significant in low back pain compensation;
specifically physically strenuous employment. It is for this reason that males were d1e
focus in this study as they are more likely to suffer chronic low back pain due to
employment in industries such as mining and construction. Interestingly recent
WorkCover statistics (WorkCover, 1998) indicate that office workers are just as likely to
suffer chronic low back pain in Western Australia due to poor posture and sitting for long
periods of time. It is important to recognise that these workers are generally more likely
to be female and, while research is inconclusive, they do appear to possess different
tolerances and attitudes towards pain compared to men (Feine, Bushnell, Miron &
Duncan as cited in Craig, Prkachin & Grunanu, 1992), which complicates cross gender
studies.
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Su!Jjective nature ofpain
Probably the greatest difficulty in the area of pain assessment lies in the inability of
objective pain assessment (Rudy, Turk & Brody, 1992) to conclusively indicate the level
of pain that an individual is experiencing (Dworkin & Whitney, 1992). Put simply,
while the tissue trauma may be identical, one patient may report much higher levels of
pain for biological reasons (less sensitivity in noinceptors, higher levels of endorphins),
for social reasons (level of anxiety at the time, level of perceived spousal support) and for
numerous other reasons (prior experience with pain). Given these reasons there is a
strong reliance on the subjective responses of the individual in pain. Self report is the
most common form of pain assessment yet "is likely to represent only a subset of what
the individual is feeling, thinking, or prepared to admit at a particular time"(Craig eta!.,
1992, 258). Lantham (1987) states "pain is exactly where and how much the patient
states it is" (p. 8). Chapman and Brena (1995) suggest that "self-report data often have
(been) found to have questionable validity, as significant discrepancies between selfreports and observed behaviours have been found among chronic pain patients for
.... activity level, social interaction and medication use" (p. 178). Overall, if one accepts
that self report is often the major source of information, given possible external goals it
can lead to the increased possibility of malingering.

An interesting experiment that attempted to combine the concept of physiological
assessment and self report was completed by Salamy, Wolk and Shucard (1983). In this
experiment, 7 chronic pain patients and 7 non-patient controls were separately asked a
variety of questions related to pain, emotional state and neutral topics. All the
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participants were assessed on specific physiological measures which have been suggested
to be useful in the detection of deception: skin potential (sweat glands) and heart rate.
Participants were assessed at specific points for each question on baseline, anticipation,
reception, processing and responding. It was found that the processing of pain questions
produced significantly larger changes in pain patients than in the non-pain controls. This
may be a potential method of detecting malingering at an early point, however
considerably more research is needed, as the number of participants is clearly very low.
What this does indicate, is the futility of relying on polygraph or 'lie detector' tests in this
area, as it will be virtually impossible to differentiate between someone lying
(presumably about their pain) and a genuine pain patient discussing their pain.

Incidence of malingering in chronic low back pain populations

There are few estimates of the variations in the level of malingering in pain populations
(Leavitt & Sweet, 1986). Probably the most often cited evidence of malingering in a pain
setting is the change in pain self-report before and after litigation (Main & Spanswick,
I 995) however this change has not been found in all studies (Mendelson, 1984a; 1992;
Suter, 1998). Several authors (Leavitt, 1985; Main & Spanswick, 1995; Lees-Haley,
1986; Leavitt & Sweet, 1986; Chapman & Brena, 1995) have suggested that chronic low
back pain patients not only present differently to those in other pain populations but they
are overly represented in populations judged to be malingering. In Leavitt and Sweet's
(1986) findings 60% of orthopedic surgeons surveyed estimated that malingering in low
back pain occurs in 5% of cases. In Chapman and Brena's study approximately 10% of
the low back pain patients were found to be inconsistent in their pain behaviour, and this
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was interpreted as malingering: This finding gives support to Leavitt's (1985) earlier
assertion that up to 10% of low back pain patients are malingering to some degree.

The reason why pain is chosen by those wishing to deceive, it could be assumed, is
partially due to the strong reliance on self report in the assessment procedures however an
additional explanation has been suggested. Lees-Haley (1986) suggested that pain is
potentially easier to fake than psychiatric disorders, as it does not require specialised
psychological knowledge of the disorder because we have all experienced pain at some
•
time. Ossipov (as cited in Cornell & Hawk,.l989) stated that "every malingerer is an
actor who portrays his illness as he understands it" (p. 382). Studies, such as Salamy et
al. (1983) appear to dispute this conclusion and as Lees-Haley (1986) offers no evidence
other than clinical experience, more research is needed before a conclusion can be drawn.

Eflect of' background on pain patients

The background of individuals can have an effect on how they experience pain. A study
by Hargraves (1996) found that individuals who participated in regular aerobic exercise
showed higher pain tolerance than those who were competing in either anaerobic activity
or no activity at all. Research by Ryan and Foster (I 967) noted that those who played
sport showed significantly higher pain tolerance and taking this result even further Ryan
and Kovack ( 1966) showed that those who played contact sports reported higher pain
tolerance than those who did not play contact sport or any sport at all. This result does
indicate the importance of viewing chronic pain as a unique state and when assessing an
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individual for pain the importance of looking at his/her history for episodes of chronic
pain to allow for a lowering in the perception of current pain

Pain assessment tools looking at the intensity of pain
There are an enormous range of pain assessment tools for assessing the intensity of pain
•
ranging from the assessment of facial expressions to the fear and avoidance behaviour
towards pain. The greatest difference lies in what the pain assessment is aiming to
achieve, whether for diagnosis where a description is needed (i.e. tearing, sharp) or a
management tool, to quickly gauge the level of intensity rather than the quality of the
pain. The pain assessment technique used in the current study, the Numeric Rating Scale
(NRS) was chosen for a number of reasons. First, it is the most widely used in the
medical setting (Jensen & Karoly, 1992). Second, because of its use of numbers rather
than a Visual Analogue Scale (VAS), in which the patient simply marks a point on a line,
which is then measured by the evaluator and numbers assigned. Using this system, the
patient can clearly indicate whether the pain is exactly the same as it was previously,
without having to remember a point on a line. Generally these lines are only lOcm,
however Jensen and Karoly (1992) recommend that the more points available, the greater
the discrimination in pain hence a 50 point numeric rating scale is used to pick up subtle
changes in pain. In Leavitt (1985), a 100 point numeric rating was used, however as
Jensen and Karoly (1992) indicate, patients often tend to use blocks of 10 rather than
utilise the discriminative potential of the scale. A compromise was the use of a 50 point
scale. The decision to use a pain measure for 5 days prior to the assessment was due to
the research by Linton and Melin (as cited in Chapman & Brena, 1995). They found that

•
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there were significant discrepancies in subjective pain when measured daily compared to
remembered pain after a delay from 3 to 11 weeks. It was concluded that retrospective
self-report data is very unreliable.

Appropriateness of the Barkemeyer-Callon-Jones Malingering Detection Scale in
emluating pain
The application of the Barkemeyer-Callon-Jones Malingering Detection Scale (1989) is
useful in pain settings due to its reliance on verbal behaviour which Reading, Everitt and
Sledmere ( 1982) suggests is the most common method in clinical settings of assessing
pain. The use of a verbal assessment tool for malingering appears to be supported by
Lees-Haley (1986) who suggests that often malingerers will begin to contradict
themselves in long interviews, they will tend to be obtrusive with their symptoms through
wanting attention and they use language differently from the genuinely ill. In short the
"malingerer's mind is on how to convince you. The genuinely disabled person's
attention is on grieving the loss, denying it and looking for a way out."(Less-Haley, 1986,
II 0). Certainly Cunni en (1997) and Barkemeyer (1998) indicate this tool is applicable
when assessing for malingering of neurological disorders however it is Hall and Pritchard
(1996) that suggest it is applicable within pain settings.

Conclusion
On the basis of the current research it appears that the MDS is an appropriate tool, to
utilise within pain setting. In addition, the measurement of the intensity of chronic low
back pain by the NRS has considerable support in both research and clinical settings. By
using just male, chronic low back pain participants, many of the issues of sex differences
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and pain syndrome type can be avoided. As a result this research would have to be
extended before it would apply to other groups.

Conceptual Issues in Malingering
The term malingering has a very specific definition, and the ramifications of this are
important to understand within the context of pain. This section focuses on the issues in
the definition of malingering, the different types of malingering, the construct of
malingering, the use of the term malingering in legislation, and the role of forensic
psychologists in assessing for malingering ..

Definition of malingering
Crucial to the current study is an understanding of what malingering represents. The
definition used by DSM IV is "the intentional production of false or grossly exaggerated
physical or psychological symptoms, motivated by external incentives such as avoiding
military duty, avoiding work, obtaining financial compensation, evading criminal
prosecution or obtaining drugs"(DSM IV, 1994, 296). Another definition is from
Mendelson (1988) who suggests that malingering can be defined as "the willful,
deliberate and fraudulent feigning or exaggeration of symptoms of illness, done for the
purpose of a consciously desired illness" (p. 196). It is specified that malingering differs
from factitious disorder as it has distinct external incentives for the symptom production
whereas the incentive in factitious disorder is just to take on the sick role (DSM IV,
1994). Evidence of an intrapsychic need as opposed to external need is required for a
diagnosis of factitious disorder. Conversion disorder and other somatoform disorders are
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distinguished from malingering as there are no external incentives in the former and
symptom rei ief is not obtained by suggestion or hypnosis. An aspect of this definition
important in the current study is that, contrary to popular thought that malingering is the
complete falsification of symptoms, malingering is more likely to be an exaggeration of
symptoms. Overall, the external goal that is often claimed is compensation from a
workers' compensation system and/or claims for damages in civil litigation (Mendelson
& Mendelson, 1996).

Malingering as a legal construe/

Despite the use of malingering as a term available to psychologists and psychiatrists, the
legal profession technically drew it from military law, making it an 'all or nothing' legal
construct. The result of this, as Mendelson and Mendelson (1993) conclude is that
while the psychiatric expert witness may draw attention to inconsistencies in the
history obtained and on examination in the mental status, poor treatment
compliance, lack of motivation during treatment or rehabilitation program, the
presence or extent of any psychiatric impairment if applicable and the nature of
or absence of a diagnosable psychiatric disorder using a specified system of
diagnostic criteria and classification, the ultimate question of the veracity of the
claimant is for the court to decide (p. 31).
Main and Spanswick (1995) also support this point noting "it is appropriate for the expert
to highlight the inconsistencies in the client's presentation of symptoms and perhaps
response to treatment but the interpretation of such findings is a matter for adjudication"
(p. 749). Despite this Mendelson and Mendelson comments that "there is no evidence of
sophisticated understanding (of malingering) by the legal profession" (1996, p. 26) so
psychologists or psychiatrists are often used as experts.

However, the psychiatric expert

is not required to 'prove' that the plantiffis a liar or indeed confirm the validity of the
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plantiff's entitlement in a compensation claim as this is the function of the court rather it
is to provide commentary on the "nature, or absence, of a diagnosable psychiatric
disorder using a specified set of criteria and classification" (Mendelson & Mendelson,
1996, p. 26).

It is vital to recognise that malingering is not a diagnosis, but in both DSM IV and the

ICD-10 (1992)(International Classification of Diseases 10

111

Edition) it is considered an

additional condition which may be the focus of future clinical attention or a category for
general record keeping purposes. Despite this, Erikson (1990 as cited in Mendelson,
1995) has found through examining medical literature and law reports that many doctors
consider the "detection of malingering as integral to the medical enterprise"(p. 428).
Regardless of the veracity of the diagnosis, Mendelson (1995) notes that as soon as a
medical practitioner uses this term in an evaluation the other will probably attempt to
seek some form of legal remedy therefore, as previously mentioned, it has more relevance
as a legal term. So in legal terms a definition of malingering Mendelson (1995) gives is
"obtaining pecuniary or other gain by falsely pretending to suffer from an illness, disease
or disability may also constitute an offence of fraud, and depending on the context of the
litigation, the simulator may also be liable for the tort of deceit and the offence of
perjury"(p. 429). The fact therefore remains that while the definition may
'psychological' it is a term that is generally used only in a legal context. Currently there
is no common law definition, and therefore the psychological definition of faking for
external gain will be used for the purposes of this paper.
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Mention of malingering in Australian Statute.\~ in which it could become the basis for a
criminal charge
Malingering is considered a specific statutory offence under some Australian statutes
such as the Workers' Compensation Acts. For example, section 188 of the Workers'
Compensation and Rehabilitation Act (1981) in Western Australia specifies:
A person who fraudulently obtains or fraudulently attempts to obtain any benefit
under this Act, by malingering or by making any false claim or statement, and
any person who, by a false statement or other means, aids or abets a person in so
obtaining or attempting to obtain, commits an offence.
A medical practitioner who is viewed as aiding the individual in this enterprise places
him/herself at risk of prosecution too. To an extent, this would make health practitioners
more likely to state that a person is malingering than to try to 'fight' for a diagnosis such
as chronic pain, which is does not often have many objective measures and risk possible
prosecution.

In Queensland, under section I J .2 of the Workers' Compensation Act (1990) it is offence
to obtain compensation by fraudulent means or by malingering while claiming an injury.
Under other compensation systems the term malingering does not appear, but it is clearly
stated that is illegal to fraudulently gain benefits under a compensation system. Further
to this, the provisions for fraud while differing within the different legislation of the states
of Australia, would probably cover this situation. Still as previously mentioned the strict
psychological definition would be utilised, it is assumed.
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Types of" malingerers
An alternative definition is offered by Travin and Protter (1984) where malingering is
viewed as a "social psychological process which is influenced by both external and
internal factors interacting with each other and serving an adaptive function" (p. 189).
External factors are the consensually perceived context and goals which make for a high
index of suspicion for diagnosing a malingering. Internal factors are the intrapsychic
state of the malingerer. Travis and Protter (1984) conceptualise this state as a continuum
ranging from malingering to malingering-like behaviour; that is; from full conscious
awareness of the behaviour to much less awareness (unconscious) of the source of the
symptoms. In this sense, the distinction can be made in terms of the conscious awareness
of the source of the symptoms, as opposed showing no understanding why the symptoms
are being produced.

Travis and Protter (1984) suggest that along the continuum there are three types of
malingerers which are differentiated by their level of awareness of the reasons for the
production of symptoms and their control over the symptoms. The first type of
malingerer is the form that the DSM IV and virtually all other definitions of malingering
use, where the patient is fully aware and control of their presentation of feigned
symptoms, that is, they are consciously producing the symptoms for a specified goal.
The second is the mid-range of category of symptoms where the patient is a malingeringlike mixed deceiver, that is, the patient is aware that he/she is feigning the presented
symptom but is not aware that other aspects of the presented symptom are beyond his/her
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control (unconscious). The third category is the end-range malingering self-deceivers
where the patient has completely deceived him/herself into realising the reality of the
presented symptoms, believing instead that it is completely feigned. Unfortunately this
topic is rarely covered in the literature, with most studies viewing malingering as a
conscious act, however, Hall and Pritchard (1996) discussed the importance of analysing
both conscious and unconscious malingering. The current study does not seek to analyse
this, and actively indicates to participants the 'conscious' state they should be in for the
assessment.

The premise that Travin and Protter (1984) follow was suggested by Fingarette (as cited
in Travin & Protter, 1984) when he said that "rather than taking explicit consciousness
for granted, we must come to take its absence for granted" (p. 190). According to
Fingarette, to be considered consciously aware an individual must explicitly state his
means of engaging the world in a clear and elaborate way (Travin & Protter, 1984). This
appears contradictory to the very concept of deception, for it is not possible to assess the
internal dialogue of an individual, and he/she is certainly not going to inform the assessor
of his/her proposed method of dealing with the world. Another problem with this type of
research is the use of case histories to support the continuum hypothesis, as all involved
psychological disorders and four of the five also involved criminal law matters. This
represents a potentially biased population of 'malingerers' from which certain judgments
have been made. Quite simply the capacity for self-delusion (or self-deception) is
naturally going to be higher for the psychologically ill, as a facet of their disorder. Travin
and Protter (1984) do make the point, that everyone is capable of malingering, as an ego
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defence. This is fraught with operational and conceptual problems and is not a topic that
will be explored. Basically the type of malingering the current study is interested in
involves primarily external gain. It is interesting to note that given the age of the Traven
and Protter's study its concepts may well have now been introduced in mainstream
diagnosis under the names of factitious disorder, somatoform disorders, and
hypochondrasis. This effectively changes the definition of malingering to one for
external gain, as the DSM IV and Mendelson's (1988) definition indicates.

Conclusion
Research into malingering is a difficult and complex process in which the definition must
be constantly restated, or else the goals can be distorted. Specifically, intent must be
shown in the attempt to exaggerate or completely feign symptoms. The use of
malingering as a form of diagnosis is clearly inaccurate and when assessing for
malingering the forensic psychologist must remember that the decision of malingering or
'fraud' is for the court. The expert can only comment on the consistency of symptoms
with the claimed disorder, not to comment on what the intent of any deviation from this
set of symptoms.

Methods of Detecting Malingering and Deception
This section of the introduction seeks to bring together some of the general research on
deception, malingering for pain and the resulting assessment issues. Firstly, this section
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will address the ability of professionals, particularly psychologists/psychiatrists, to be
able to accurately assess those who are malingering and why this might be the case.
Secondly, a variety of different psychological techniques or indicators for assessing for
malingering will be presented. Thirdly, a physiological method of assessing for
malingering for pain will be presented.

Fourthly, a range of different methods that have

been developed to assess for chronic low back pain will be presented. Fifth, an
examination of the different methods of research into this area will be made. Finally,
some comment will be made in regard to the application of malingering scales, and the
importance of other factors. These points will then be explained in terms of the current
study.

Recent interest in malingering as part of the deception literature

There has been increased interest in malingering, however despite its importance to
clinical and forensic practice, it remains relatively unresearched. Malingering appears to
be largely viewed as deception in the medical and/or psychological context, and most
texts on deception (Rogers, 1988; 1997; Hall & Pritchard, 1996) give the topic
consideration. The 'science' of detecting deception has undergone considerable change
largely due to work reported in the book Clinical Assessment of Malingering and
Deception ( C' and 2"d Editions) edited by Richard Rogers (1988; 1997). This appeared to
stimulate considerable comment and research into the field. Two significant areas were
noted where a professional shift appeared to occur. First, the professions had to accept
that there was a relatively poor ability exhibited by staff to successfully detect deception
and second, that deception, and especially malingering is very difficult to detect. Indeed
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recent research has suggested that the level of malingering in forensic evaluations may be
as high as one sixth of all evaluations (Rogers, Salekin, Sewell & Goldstein as cited in
Rogers & Cruise, 1998) the need for increasing knowledge in this area is clear. While on
first impressions this figure is questionable give Cornell and Hawk's (1989) finding that
in 314 psychiatric/legal evaluations approximately 8% of individuals presenting were
'diagnosed' as malingering, when the standard deviations in Rogers Salekin, Sewell and
Goldstein are examined it is clear that both estimations fall within the same range.

Psyc!wlogists sometimes cannot disti11guish .between those clients/participants faking and
genuine clients/participants

Increased focus has been placed on the ability of health professionals to detect deception.
Since Rosenhan's (1973) classic study in which pseudopaticnts were admitted to a mental
institution and diagnosed as having major psychiatric disorders, the medical and
psychological professions have been forced to admit that occasionally they are fooled.
Heaton, Smith and Lehman (as cited in Faust, 1995) found that neuropsychologists
performed at only up to 20% better than chance when they attempted to differentiate
between faking litigating individuals and genuine non-litigating participants. Faust,
having reviewed limitations of malingering research, concluded that "clinicians' capacity
to detect feigned emotional or cognitive disturbance is in doubt .... contrary claims for
proficiency at the task lack adequate scientific support" (1995, p. 57).

Evidence differs as to the ability of psychologists and other health professionals to
successfully gauge whether an individual is malingering. Ekman and O'Sullivan (1991)
indicate that, in general, health and legal professionals are not good at detecting faking
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and due to the strength of the inverse relationship between the confidence of the
professional and accuracy in detecting faking, this situation does not appear likely to
change. Weintraub (1995) suggested that it is relatively easy to fool psychologists and
pain experts (Faust, Hart, Guilmette & Arkes; and Faust, Hart & Guilmette, as cited in
Weintraub, 1995). In contrast, Cornell and Hawk (1989) found a relatively high
reliability between forensic psychologists, regarding the accuracy of diagnosis of
psychiatric patients regarding malingering (35 malingerers and 25 genuine patients),
suggesting that when a formalised series of symptoms are addressed the accuracy level
rises. While this is useful in psychiatric settings it should be noted that research has
already indicated that it is not difficult to deliberately score poorly on pain evaluation
tools (Frazen, Iverson & McCracken as cited in Weintraub, 1995).

Why clinicians do not appear to be able to accurately detect an individual attempting to
malinger
Faust ( 1995) has suggested that certain distinct factors underlie the research findings into
why practitioners sometimes do incorrectly assess a person as not being deceptive. These
reasons are clinical orientation, dependence on soft methods and evidence and finally the
tendency of practitioners to underestimate the skills of their 'patients'. Simultaneously
practitioners are overconfident in their ability to assess malingering. The orientation of
clinicians is traditionally to assume dysfunction and sympathise with their patients.
Indeed the training health care professionals receive is "based on an orientation
emphasizing supportive, empathic and healing forms of rapport building, rather than
attempts to penetrate deception"( Lees-Haley, 1986, 110). Further to this Faust (1995)
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notes that when the physician's primary obligation shifts from the patient to uncovering
the truth, he/she may now be an adversary rather than a support. As Chapman and Brena
( 1995) indicate there is a dependence in many conditions on the report of the patient for
such information as history and symptomatic complaints.

Faust (1995) indicates that when plantiffs withhold or distort information about important
issues that may account for symptoms, such as pre-injury condition or substance abuse,
limitations in methodology and knowledge makes it difficult to determine whether his/her
presentation makes sense medically. Finally, often patients are underestimated by the
evaluator, in their knowledge, preparation and skills. Indeed some malingerers gain
access to the literature on malingering assessment instruments, to help them avoid
detection. This issue will be addressed later. Faust (1995) indicated that as the
confidence of the practitioner increased their ability to detect malingerers was reduced.
So when practitioners don't complete external checks on subjective information and
instead follow clinical lore, which has not been properly validated, then they may be
deceived (Faust, 1995).

A variety ofpsychological approaches have been suggested to detect malingering
The American Psychological Association (A.P.A), through the DSM IV (1994),
acknowledge that malingering may be very functional. An example might be feigning
sickness as a prisoner of war. In addition they suggest that beyond functionality,
malingering should be "strongly suspected" when any combination of the following is
noted: "medicolegal context of presentation, marked discrepancy between the person's
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claimed stress or disability and the objective findings, lack of cooperation during the
diagnostic evaluation and in complying with the prescribed treatment regimen, and the
presence of Antisocial Personality Disorder"(p. 297).

Hall and Pritchard (1996; Paulsen & Hall, 1991) advocate that a framework be used when
assessing deception rather than just relying on intuition. Paulsen and Hall (1991) have
suggested that any assessment of malingering be broken into three areas: before, during
and after the evaluation. Prior to the interview, Paulsen et al. (1991) suggest that the
evaluator must gather source material, maintain independence from the referral party,
assess examiner distortions and remain vigilant to the possibility to distortion. During
the evaluation it is suggested that the interview is recorded, that questions are openended, focus is given to critical distortion issues, multiple assessment measures are used
and the assessee is confronted with suggestions of distortion. After the evaluation
Paulsen et al. (1991) recommend that the interviewer assess nondeliberate distortion of
the assessee, differentiate between incident and evaluation distortion, report incomplete
or invalid data and identify a feedback mechanism. The MDS can clearly fit into this
model, however this model while providing suggestion does not specifically give a
decision making framework for deciding whether an individual is malingering or not.
Hence, the MDS and other deception detection tools, such as the SIRS, are still required
to be part of any test assessment battery.
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According to Faust (1995) there are currently three methods of detection: responses to the
Minnesota Multiphasic Personality Inventory (MMPI) I and 2, symptom validity testing
and atypical performance patterns in specialist assessment tasks. Mossman and Hart
(1996) have suggested that clinical methods, malinger profiles and external information
be used to make decisions about malingering. It should be noted however that Rogers
and Salekin (1998) have noted significant problems with many of the approaches that
Mossman and Hart (1996) advocated. These are too numerous for this paper to address.
The MMPI has long been used as a malingering assessment instrument, as it assesses
certain personality correlates. The F score and obvious items are often elevated for
malingerers. The subtle items generally have a normal response rate as malingerers
cannot distinguish which direction indicates abnormality. There is still some debate over
the efficacy of the MMP1 (J or 2) at assessing malingering. Various meta-analyses have
suggested that MMPI I (Berry, Baer & Harris, 1991) and 2 (Rogers, Sewell & Salekin,
1994) have found different validity scales are able to distinguish between the malingering
or defensive group and the group taking the test honestly. In terms of external validity
Greene ( 1997) points out that research has found that MMPll and 2 has greater difficulty
in distinguishing between the group instructed to malinger and actual patients than
between simulators and normal individuals. Greene (1997) reported that the malingering
a wide range of different disorders on the MMPI 1 and 2 have found that the malingering
group could be distinguished, however the more severe psychopathology, the easier it
was to detect malinger. A sobering point made by Berry, Lamb, Wetter, Baer and
Widiger (1994) is that due to such widespread research and use the MMPI-2 has lost
some of its integrity. Indeed Berry et al. (1994) suggest that the widespread publishing of
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information about the MMPI-2 has reduced its effectiveness as a psychological
assessment tool.

Symptom validity testing, which often involves a forced choice format, has been used in
an attempt to make the malingerer overplay his 'sick' role and perform at a level lower
than chance. In time this can produce evidence of systematically produced incorrect
results. The major problem with this format it that it has limited sensitivity and if the
feigned deficits are not gross, then the malingerer will not be detected (Faust, 1995). If
these can be refined, it may represent an excellent method. Both the SIRS and the MDS
utilise this format by suggesting improbable symptoms of a disorder for which there is no
medical evidence. This is known as a false choice format but represents the overt
agreement with any indication of disorder. This is, to an extent, utilised by the MDS.

Faust (1995) suggests that in time other approaches will be developed to detect
malingerers such as reaction time and atypical patterns on cognitive tests. Mossman and
Hart (1996) support such an approach with a distribution of scores on malingering
assessment tools indicating probability of malingering rather than arbitrary cut off scores.
This, it was suggested, is especially useful when presenting evidence of malingering to
the court, however this will be commented upon later. Overall these approaches are still
in the experimental stage and similar to symptom validity testing require significant
levels of research before probability tables and profiles (typical versus atypical, age
appropriate, gender based) can be generated which would allow this format to be used on
a wide scale.
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Main and Spanswick ( 1995) have suggested certain features which "should alert the
assessor to the possibility of simulated incapacity" (p. 748) in which some are primarily
suggestive of malingering and some are not. These features appear to be relatively
similar to those described by the DSM IV. Features they suggest are primarily suggestive
of malingering are: failure to comply with reasonable treatment, report of severe pain
with no associated psychological effects, marked inconsistency in effects of pain on
general activities, poor work record, history of persistent appeals against awards and
previous litigation. Features that are not considered primarily suggestive of malingering
are: mismatch between physical findings and reported symptoms, anger, report of severe
or continuous pain, poor response to treatment and behavioural signs/symptoms. This,
rather than being overly inclusive, gives some indication of areas in which malingering
can be differentiated from associated pain disorders. While not in complete agreement it
is interesting to note that Leavitt (1985) found that simulating malingerers reported 21%
more clinical pain than actual patients and further focus on this result will be made.

Chapman and Brena (1995) has proposed that due to problems with self-report in pain
assessment a label of malingering should only be diagnosed from a consistent pattern
among multiple indicators. In their evaluation 175 low back pain patients were used, for
reasons similar to the current study; the literature suggests that back pain is both common
and often considered suspect. The method of assessment utilised client self report,
physician assessment and three independent raters. The physician assessed all the
patients involved in the study on a number of different measures. During the verbal pain
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reports the level of dramatization was assessed. A rating was given on the severity of
medical findings involving muscle strength, joint mobility, trigger points, sensory and
motor losses, and results from radiological and other studies of severity. An assignment
was made to one of the four categories in the Emory Pain Estimate Model. This model is
based on medical findings, MMPI scales, drug intake and indices of pain behaviour. The
patient's response to lumbar sympathetic two injections of saline and at least two
injections of .25% bupivacaine was recorded. A rating of drug use during the week prior
to treatment and the last week of treatment was made. This was based on subject's
records of medication and was divided into classes of drug type: narcotics,
sedatives/hypnotics, minor tranquillisers, phenothiazines, antidepressants, nonnarcotic
pain medication and other drugs for pain. Each class was given a label of "no use"
(averaging less than three tablets per week) or "use" (over three or more tablets per
week). Finally a rating of physical impairment, in accordance with the AMA Guides for
Evaluation of Permanent Impairment was given.

A physical therapist and psychologist, both gave independent ratings at the end of
treatment relating to the patient's overall "attention and interest" in treatment, and "focus
on pain". The physical therapist also gave ratings on each patient's "compliance with
recommended exercises". All of these ratings were based on five categories ranging from
very low to very high. Some patients were referred for an EMG examination where the
consultant running the procedure was asked to rate whether he observed inconsistent
tensing of a muscle that suggests that this patient was showing "submaximum effort" to
fully contract the muscles during the examination.
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The self-report data that was administered involved five paper and pencil measures. An
MMPI was given at the start of treatment. An Activity Diary listing activities involving
movement on one's feet was kept and a score indicating the mean daily total of minutes
spent moving on one's feet was calculated for one week prior to treatment and the last
week of treatment. Subjective pain intensity was assessed using a 0 - 100 visual
analogue scale with end points labelled "no pain" and "pain as bad as it could be" was
used to measure pain at the beginning and end of treatment. All the treatments offered
were rated by patients as being "very helpful", "somewhat helpful", "not helpful" or
"harmful". Finally the Multidimensional Health Locus of Control questionnaire was
given halfway through the treatment to assess the extent to which patients saw their
health as being dependent on their own actions.

Of 143 participants in Chapman and Erena's (1995) study, 17 inconsistent participants
were unanimously rated by all three evaluators as showing at least one inconsistency.
The behaviours judged as inconsistent covered a very wide range. First, contradictory
statements to different staff members regarding pain, medication or compliance were
made. Second, exhibiting behaviour which they have either claimed they could not do or
they claimed to have clone exercises but had not actually done them. Inconsistent patients
were generally younger; all were inpatients, whO have pending litigation or current
disability status. These patients exhibited a higher focus on pain and clramatised
complaints, however all had a low level of medical evidence to support their claims. Not
surprisingly these patients had a low level of interest in treatment, show a poor
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compliance to treatment and low level of physical activity. The flaw in this study which
relates to the concept of an intent that the current study hopes to redress is that all the
inconsistent patients were inpatients which suggests the possibility of institutionalization
or at least some abnormal illness behaviour due to the environment. Chapman and Brena
(1995) note that it is difficult to assess whether inconsistency was conscious or not, and
issues such as institutionalisation take the conscious element out of the inconsistency. If
this intent cannot be assessed then the issue may now not be malingering but rather
factitious disorder or conversion disorder.

The difficulties of the differential diagnosis of malingering and factitious disorder with
physical symptoms have been canvassed by Overholser (1990). He highlights important
issues such as the strong similarity between malingering and many other pain or illness
'disorders'. Overholser (1990) has indicated that there are 4 domains in which
differential diagnosis can be made: observed symptomology, course over time, response
to treatment for somatic conditions and proposed etiology. Observed symtomology
includes somatic symptoms, actual tissue damage, behaviour during interview and the
typical setting in which each is encountered. The course over time looks specifically at
onset of somatic symptoms, duration of episodes, discharge status, stability of problems
and recurrent episodes. The patient/client's response to treatment for the somatic
symptoms includes the nature of treatment provided, somatic response to this treatment,
emotional response and behavioural response. Finally, the proposed etiology looks at the
production of symptoms, control over symptoms, primary sources of motivation, external
motivation, internal motivation and presumed personality. When this set of criteria is
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used to actually differentiate malingerers and those with factitious disorder with physical
symptoms, it appears the major differences occur in the proposed etiology through
internal (factitious disorder) and external (malingering) goals, probable type of treatment,
behavioural and emotional response to treatment, whether discharged by doctor or self,
whether actual tissue damage has occurred and whether an outpatient or inpatient.
Overall, Overholser (1990) acknowledges that this set of criteria has not been validated,
and he is relying on clinical observations for his evidence in malingering. What this does
demonstrate is the heavy reliance on assessing motivation (internal or external), even
when conscious production of symptoms can be proven, in order to 'prove' malingering.

Hall and Pritchard (1996), presumably from clinical experience, have suggested that as
malingerers would wish to avoid evaluators and treatment personnel, certain behaviours
related to evaluation may be indicative of malingering. Behaviours such as the number of
hospital admissions, length of stay in hospital, number of diagnostic procedures in
hospital, help-seeking in regard to rehabilitation centres, days lost from work and number
of patient-physician contact or specialists consulted constituted malingering. Hall and
Pritchard (1996) have suggest a number of detection strategies; anatomical
inconsistencies, drug responses discrepancies, clinical interview behaviour, presence of
psychometric, inconsistency in community versus evaluation behaviour and lack of
response to common interventions, Pritchard anti Hall (1996) have noted that all chronic
pain and sensation-loss syndromes can be targeted for deception. They did make the
point however that evaluators should not confuse complainers with fakers. Matheson (as
cited in Waikar eta!., 1991) introduced the term symptom magnification syndrome as an
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alternative to malingering in which the behaviour has an imputed motivation. Symptom
magnification syndrome separates that behaviour from the motivation (Waiker et al.,
1991), but Bourg, Connor and Landis (1995) argue that it is the circumstances that are
crucial to the reason for the assessment, and therefore the assessment cannot be done in a
vacuum.
A purely physiological me/hod (~f" assessing malingering in chronic low back pain
populations
A physiological method of screening for malingerers using chronic low back pain was
developed by Waikar et al. (1991) following work by Daniel ( as cited by Waikar et al.,
1991) and Kroemer and Marras (as cited in Waikar et al. 1991). Waikar et al. (1991)
researched this area with three groups. The first group were healthy and were told to
exert maximum lifting strength. The second group were also healthy but were told to
only use half their effort. The final group were chronic low back pain sufferers who were
told to exert their maximum safe strength without incurring pain or discomfort. The
static strength measures were conducted in both the "squat" and "stoop" position that
Chaffin (as cited in Waikar et al., 1991) suggested in accordance with the standardisd
procedure proposed by Caldwell, Chaffin, Dukes-Dobos, Kraemer, Laubach, Snook &
Wasserman as cited in Waikar et al., 1991 ). A single maximal voluntary contraction has
a force output based on time for a sustained 5 second period. The strength score was
taken as the mean value recorded in the middle three seconds of the exertion. A slope
score is generated by the amount of weight lifted per second.

The finding of Waikar et al. 's ( 1991) study was that the average amount of force
produced by the healthy subjects only trying with 50% exertion was only 38% when
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compared to the maximum exertion of both the healthy subjects and the chronic low back
pain patients. Across all three groups the average lifting strength was greater in the squat
position than in the stoop position. Interestingly, the average strength scores for both the
healthy subjects using their full exertion and the chronic low back pain patients were
almost identical in each lifting condition. As no significant differences were found
Waikar et al. (1991) suggested that this measure was inappropriate in distinguishing
between chronic low back pain patients and healthy patients not exerting maximum
effort. Using discriminant analysis based on seven variables from the strength testing
yielded an accuracy rate of 91% but tended to misclassify more low back pain patients.
The strength testing variables used were: mean strength for ten trials, strength standard
deviation, mean slope for 10 trials, mean range for lO trials, mean range/score ratio, ratio
standard deviation and ratio coefficient of variation.

To use this method, Waikar et al. ( 1991) suggest that a participant be asked to exert his or
her safe maximal strength each time in I 0 trials following the protocols outlined. After
calculating the values of these strength measures they could be inputed into the developed
discriminant model, which would classify this person as either healthy and giving
maximum effort, healthy but giving submaximal effort or having back injury and giving
safe maximal effort. Clearly if the individual is classified as giving submaximal effort
then it possible that they are malingering or symptom magnifying according to Waikar et
al. (1991). Finally, it is recognised that this represents only an additional diagnostic tool
for chronic low back pain and should be used in conjunction with other measures. Faust
(1995) has indicated the problem with many of these physiological assessment
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instruments, is that they must assume motivation to produce maximum effort; and it is
there that the deception lies. The MDS does attempt to assess motivation, albeit in a very
blunt manner, through the questions found in Part 2. The effectiveness of establishing
motive does appear to be an field that is profoundly under-researched and given the
definition of malingering, one that will need increased attention.

Malingering screening tools specifically designed for chronic low back pain
Screening tools for malingering, such as those used by John Hopkins Chronic Pain Centre
(See Appendix 2) (Long, 1986), have been developed for specific reasons but generally
they are not based on research. They tend to reflect an in-house approach to assessment.
There are even malingering screening measures for back pain available on the Internet
through the Mensana Pain Clinic (Mensana Pain Clinic, 1997) (Appendix 3). What is
clear with both these instruments is that they rely heavily on examining the economic and
social circumstances of the individual with back pain. This essentially is an examination
of the conditions for which a person may have reason to malinger, that is, financial
difficulties or attitudes to work. As with litigation, while the circumstances may be
conducive to malingering, this is not evidence of the act. Put simply it is the difference
between a motive and intent- with intent being the crucial factor in the definition of
malingering.

A study by Leavitt (1991) using a low back pain simulation scale to predict disability
time, evaluated the endorsement of different 103 pain words by 1679 individuals injured
at work. This was developed following Leavitt's (1985) early work with simulating
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malingering for low back pain when compared to genuine pain patients in which the
results suggested that people who simulate back pain employ different pain language than
those with clinical pain. Leavitt (1991) suggests that the low back pain simulation scale
utilises 45 words that can differentiate those simulating from those with genuine pain.
After administering this scale it was suggested 10.4% were in the simulating range, with
this sample indicating that they felt more intense pain and would be disabled longer. A
known groups design was utilised in which, the participants identified as simulating
(10.4%) had generally previously been labelled as possible malingerers. The problems
with this sort of design will be examined later. Overall this group had indicated that they
experienced 21% more pain than those found not to be simulating. This is not surprising
if the pain words identified as indicative of conscious exaggeration are more extreme in
their intensity than the 'normal' pain language. In addition, the individuals who had been
off work for over a year accounted for 33.9% of the high simulation group and 19.3% of
the low simulation group. Leavitt (1991) suggests that, even when 25 participants from
the high simulation range and 25 from the low simulation range and then rated by
physicians for organic pathology and confidence that the individual is malingering there
is a significant level of discriminative ability for those labelled as high simulators. In
short, those with less tissue pathology report more pain and record the longest time for
disability.

When validating or developing measures to assess malingering several problems emerge.
Chapman and Brena (1995) note that it is virtually impossible to gain access to a
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population of known malingerers, as by definition, these people make sure that they arc
not identified. This leads to two possibilities, the first being identifying participants who
were inconsistent in their responses and therefore are probably malingerers or
alternatively using a simulation design in which participants are asked to simulate
malingering.

Several studies have used simulation designs for back pain (Leavitt, 1985; Clayer,
Bookless & Ross, 1984) in which participants without back pain were asked to simulate
low back pain when completing certain written evaluation tasks. These responses were
then compared to the responses of authentic low back pain patients; and in both cases the
evaluation tool showed differences between the two groups in the endorsement of pain
words and cognitions relating to illness behaviour.

A major study, which from the results and methodology, was a significant basis for the
current study is Leavitt (I 985). Following from work on pain descriptors by Melzack
( 1975), Leavitt ( 1985) sought to use pain word descriptions as a means of differentiating
between clinical and simulated low back pain. Basically he used 103 pain terms which
covered the range of sensory and affective sensations typically reported by patients with
low back pain. Eighty seven items were drawn from the Low Back Pain Scale (Leavitt,
Garron, Whisler & Shenkop as cited in Leavitt, 1985). The remainder came from a
general review of the clinical work on low back pain completed as part of the
development of the final scale. There were two groups of participants: 553 patients with
low back pain and 347 participants, obtained from the Chicago directory, who were asked
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to "play the role of a person who is trying to convince a doctor that their back pain is
severe enough to stop them from working at their regular job" (p. 497). This instruction,
arguably then limits the type of low back pain, to being mechanical in origin rather than
pathological or traumatic which Giles and Crawford (1997) have suggested are
physiologically different. However for the purposes of this study, traumatic pain, is of
greater interest, making this set of instructions slightly inaccurate.

A predecessor of the Barkemeyer-Callon-Jones Malingering Detection Scale was the
Conscious Exaggeration scale (Clayer et al.,-1984) based on the Illness Behaviour
Questionnaire (IBQ) (Pillowsky & Spence, 1983). The IBQ was designed to assess
abnormal illness behaviour whereas the conscious exaggeration scale was designed to
differentiate between control participants, conscious exaggerators and those with neurotic
pain. Pilowsky (1994) indicated that he did not consider that abnormal illness behaviour
was the same as malingering. This will be discussed later. While not the same as
abnormal illness behaviour there are similarities between this diagnosis and factitious
disorder with physical symptoms, and given Overholser's (1990) highlighting of the
similarity between factitious disorder with physical symptoms and malingering
Pilowsky's ( 1994) comment clearly needs to be clarified. The study used a simulation
design, similar to the one employed by the current study. Results showed that a
conscious exaggeration scale could

differentiate~

at a significant level, between

malingerers and those with neurotic pain, and between people with neurotic pain and
controls.
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In Clayer et al.'s (1984) study the items that differentiated the three groups most
dramatically, as they were endorsed by the participants asked to exaggerate, fell into a
wide range of cognitions. The most common (endorsed by over 75% of participants
asked to malinger) groupings of items were: the participant thought there was something
seriously wrong with his/her body, that other people did not recognise the seriousness of
the problem and issues of depression. These clearly are not sufficient to objectively
differentiate between malingerers and those with chronic pain, from a diagnostic
perspective, and only suggest a general sense of catastrophising the level of impairment
resulting from the pain, something that genuine patients do not to tend to do due to
experience. Mendelson (1987) completed a study in which the conscious exaggeration
scale (from the IBQ), a visual analngue scale and a list of pain related adjectives from the
McGill Pain Questionnaire were given to chronic pain patients some of whom were
litigating and others were not. It was found that conscious exaggeration scale could not
distinguish between those litigating and those not. Mendelson (1987) ultimately suggests
that there is "a high correlation between scores on the Conscious Exaggeration scale and
personality factors, especially anxiety proneness, state anxiety, depression and hostility"
(p. 709). The impact of this will be discussed later.

The current study seeks to use a simulation design, the difference being that all the
participants are pain patients half of whom will "be asked to consciously exaggerate their
pain. When Clayer et al. (1984) conducted their research chronic pain was considered a
neurotic condition hence the inclusion of neurotics as participants; this is no longer the
case (Turk & Melzack, 1992). The flaw in this study that the current study seeks to
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redress is that conscious exaggeration, can, by definition, only occur when some form of
pain is felt, that is, something exists which can be exaggerated.

Currently no study has attempted to validate the Barkcmeyer-Callon-Jones Malingering
Detection Scale (1989) which, at this stage, seems to be the only malingering scale based
upon research that purports to be applicable in pain settings. The Barkemeyer-CallonJones Malingering Detection Scale has only been cited on four occasions: Dannebaum
and Lanyon (1992), Hall and Pritchard (1996) and recently Cunnien (1997) and Smith
( 1997). Donnebaum and Lanyon ( 1992) cited it as an example of subtle items in the
detection of deception. Hall and Pritchard (1996) cited and reproduced the scale, in their
book, as an example of an assessment tool for malingering for pain or Joss of sensation.
Similarly, Cunnien (1997) describes the scale but does not cite any validation procedure
completed on the MDS by an independent body. Smith (1997) comments in the most
detail on the MDS, and this will be discussed later.

Even when malingering assessment tools are developed certain procedures, if followed,
give the assessment consideral7/y more validity
Even when clinical tools are available for malingering Faust (1995) suggests several
guides for the clinician, which will, he claims strengthen the health professional's
position in the courtroom. First, it is important not let subjective confidence be the guide
for whether an individual is malingering. A study has shown that clinicians who
indicated that they were confident or very confident in their diagnoses had an error rate of
LOO% (Faust, Hart & Guilmette as cited in Faust, 1995). This may be due to the
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relationship between overconfidence, premature conclusions, insufficient data collection,
failure to use useful diagnostic procedures and decision rules (Kahn em an, Slavic,
Tversky as cited in Faust, 1995). Second, consider the degree to which the examinee has
a motive to deceive, which cao be extremely difficult to ascertain in legal proceedings,
where there may be strong incentives to deceive. Faust ( 1995) suggests that "under such
circumstances, the base rates for malingering is higher, and thus the index of suspicion
needs to be greater, diagnostic thresholds need to be adjusted and more thorough and
systematic assessment is indicated" (p. 261 ). It is interesting that no papers are cited to
support this contention, and similar to Leavitt and Sweet's (1986) finding, it appears to be
part of clinical folklore. The current study seeks to assess this link between the court
process and malingering.

Conclusion
The literature on detecting malingering clearly gives disparate results. Certainly the
ability of clinicians to detect malingering appears to be in doubt however the ability of
standardised testing appears to be proven yet. Clearly, one cannot rely on one method to
substantiate the other, which is what effectively occurred in the original validation of the
MOS. Specifically, the detection of the malingering of pain has been approached through
both physical and psychological methods. Neither has been proven conclusively and
generally the methodology used to 'prove' the capacity of a malingering assessment has
been controversial. While certain factors such as extreme responses on pain intensity and
attitude to treatment, when compared to genuine patients, are suggested by the research,
no conclusive technique has been found to address the element of why a pain patient is
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attempting to malinger. This is crucial, given the criteria for malingering. What is
perhaps more difficult to operationalise is the distinction between simulators being given
a motivation and a 'real' malingerer, where there are perhaps multiple motivations and
rationalisations within them.

Chronic Pain and Litigation
The relationship between litigation and chronic pain is well established, however
it appears to lead to certain assumptions being made about those in litigation with chronic
pain. Litigation, whether through a no fault system or a common law remedy, relies
heavily on pain and suffering for the final level of compensation and this must prove
tempting for those willing to manipulate the system. Several studies have indicated that a
high degree of suspicion exists towards particularly low back chronic pain patients who
are attempting some form of litigation. Interestingly while research suggests that there is
little relationship between litigation and malingering, the stereotype still appears to be
prevalent.

Pain is often central in litigation
A survey of only six plantiff attorneys

indicat~d

that in 1989 they handled a total of 69

cases involving back injuries for settlements totalling approximately 7 million dollars
(Aghazadeh as cited in Waikar et al., 1991). With this in mind, Weintraub (1995) notes
that people are compensated for "subjective and intangible pain and suffering, loss of
consortium, and loss of life's pleasures ... despite the fact that these losses cannot be
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quantified, they are responsible for 80% of the reward" (p. 341). This system must prove
tempting for some individuals to attempt to manipulate for personal gain, especially given
the level of awards involved

Involvement as a litigant, whether prior or current, appears to be cause for suspicion of
possible malingering
The comments by Faust (1995) and the DSM IV (1994) suggesting that litigation is an
excellent indicator of the possibility of malingering are by no means unusual. Leavitt and
Sweet's (1986) study, using a sample of 113 orthopedic surgeons, found that 50% of this
group considered that when a back patient indicated that they were involved in some
form of litigation or were considering becoming involved, could be considered a sign
that this patient may be malingering. In support of this Chapman and Brena (1995) found
that inconsistent participants (suspected of malingering) in their study were likely to have
pending litigation or to be receiving current disability income and report a higher degree
of pain. Main and Spanswick ( 1995) suggest that previous litigation is a strong indicator
of the possibility of malingering. As malingering is strictly a legal term although a
psychological definition is utilised, this may be acceptable, however the interest for this
study is whether this assumption is correct. Travin and Protter (1984) lend some support
to the study's approach when they state
"malingering-like phenomenon ..... are utilised in a wide range of perceived
adaptive circumstances; and just as lying behaviour can blur and merge into
subtle forms of self-deception it is only within the forensic context that with its
sociopsychiatric and medico-legal overtones that one scrutinises the obvious
motivations for the act" (p. 198).
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Need to factor in legal system for any malingering validation especially one in which
personal injwy litigation is i111Jolved

As part of the validation of the MDS there needs to be a validation with those individuals
who are aware of the rewards associated with malingering due to the sort of system that
they have been operating in. The validation of the Structured Interview for Reported
Symptoms (SIRS) (Rogers, 1988) is an excellent example of such a validation process.
The SIRS is used in psychiatric settings to assess malingering, and, as with malingering
measures, it primarily relies on assessing inconsistency in responses. The validation
process the SIRS has undergone shows the value of simulation designs to assess the
potential problems that a malingering population may present to a new scale such as
discriminant and concurrent validity (Rogers, Gillis, Dickens & Bagby, 1991). In
particular their ability to assess faking in a number of specific disorders (Rogers et al.,
1992) and the effect on coaching on the discriminative ability of the scale (Rogers, Gillis,
Bagby & Monteiro, 1991). For a complete validation the Barkemeyer-Callon-Jones
Malingering Scale will have to show similar discriminative levels under similar
conditions. It is for this reason and the influence of Leavitt and Sweet's (1986) findings
that the responses of pain patients who have been involved in workers' compensation
systems and/or legal system will be compared to the responses of pain patients who have
not had contact with any adversarial system.

Research in this area is difficult because, it is difficult to know the level of pain prior to
the injury, and then the effect of anxiety regarding financial concerns for the future. So
studies that have indicated that perceived pain levels dropped after the litigation was
completed (Mendelson, 1992) may be indicative of stress relief rather than malingering.
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Certainly research by Guest and Drummond (1992) does suggest that no significant
difference exists between litigants and non-litigants after the court process, and that
emotional distress was not necessarily lessened after the court case. This research was
slightly different to the current research as it utilised chronic low back pain sufferers who
went to court and compared them to those who settled their claim prior to court. In the
current research both groups would all be in the litigating group. Weintraub (1988) stated
that chronic pain is generally regional, involving the back, neck, limbs or head however
during litigation the locations of the symptoms are not random. Instead they seem to be
concentrated in the functional domain of the sensory and motor systems of the injured
area. This can be interpreted in a number of ways: malingering, compensation
neurosis/accident neurosis or abnormal illness behaviour. Interestingly, Clayer et al.
(1984) proposes that Pilowsky (as cited in Clayer et al., 1984) clearly includes
compensation neurosis within his conception of abnormal illness behaviour, which would
appear to negate a label of malingering under the current definition, requiring specific
intent.

Compensation neurosis
Compensation neurosis has been termed by Foster Kennedy (as cited in Mendelson,
1992) as "a state of mind, born out of fear, kept alive by avarice, stimulated by lawyers
and cured by a verdict' (p. 121). It has been suggested by Miller (as cited in Clayer,
Bookess-Pratz & Ross, 1986) that there is substantial difficulty in distinguishing between
compensation neurosis and malingering. Further to this Miller, in the same article, made
the important point that such a term automatically prejudices an individual's case as it is
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in effect an accusation, which presumes to understand the motivation of the patient
(Voiss, 1995). Specifically the difference, it has been suggested, lies in the concept of
conscious and unconscious motivation. Miller states that
whether such exaggeration is conscious or unconscious is a question often by
debated by lawyers and psychiatrists in court. To many psychiatrists it represents
no problems, and they authenticate the complainant's unawareness of motivation
with confidence that seems impressive- until one reflects that the differentiation
between conscious and unconscious purpose is quite imperceptible to any
scientific inquiry and that it depends on nothing more fallible than one man's
assessment of what is probably going on in another man's mind (p. 296).
Hall & Pritchard (1996) express similar sentiments regarding the ability of an assessment
to discern conscious deception from unconscious deception. This has probably lead to
more accurate but no less difficult terms such as 'patterns of conscious failure to provide
accurate self-report data' (Main & Spanswick, 1995) which has been used, perhaps to
avoid the decision between conscious and unconscious exaggeration.

Studies specifically addressing the c[f"cct of litigation on chronic pain
All of the few studies that have looked at chronic pain in litigation, support Mendelson's
(1982) contention that patients arc not 'cured by a verdict'. Peck, Fordyce and Black
( 1978) studied the different response styles to chronic pain by claim tort litigants
compared to non-litigants. Whilst acknowledging that there were very few differences
between the two groups they did find that two pain behaviours identified the litigants.
The litigants consulted fewer doctors and used-more supportive devices such as crutches
and prosthetics that cost more than $200. Non-litigants used more prescribed pain
relieving medication than the litigants in the first month after injury however, by the sixth
month, drug ingestion was significantly reduced for both groups.
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There does not appear to be a significant difference between litigants and non-litigants in
the self report of pain intensity. Mendelson (1984a) compared 47 chronic low back pain
patients with 33 chronic low back pain patients not seeking compensation and found
using a visual analogue scale, that there was no difference between the two groups in the
level of reported pain intensity. This study was conducted close to or after litigation was
completed which does not necessarily capture the levels of pain during the litigation
process. Suter ( 1998) found that when litigants and non-litigants were compared on
levels of pain and anxiety before, during and after litigation, there was a definite increase
during litigation which returned to normal levels later. However the confounding
relationship between pain and anxiety can be used to explain this result (Hawkins &
Price, 1992; Guest & Drummond, 1992).

There is Iittle doubt that there is substantial anxiety for litigants in the court process
which the rise of therapeutic jurisprudence movement has shown (Wexler & Winnick,
1996). Leavitt's ( 1990) study into emotional distress among patients with chronic pain
showed that patients with such an issue, were more likely to have a longer period of
disability irrespective of whether they were in receipt of compensation payments. This
interaction between response to litigation and injury has been addressed in a number of
studies

An interesting analysis, completed by Binder, Trimble and McNeil (1991) showed that
the relationship between financial compensation and outcome was reliant on several
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different factors. The methodology utilised 18 participants who had complained of
psychiatric symptoms during the litigation process and were recruited from a
psychiatrist's files. Through reviewing the court documents and interviews with the
participants, Binder et al. (1991) developed case examples which appeared to
demonstrate complicated relationships between monetary compensation and outcome.
Certainly some of the participants reported that they had improved after they had received
compensation, however this appeared to be related to issues besides the money. Reasons
such as feelings about impairment, family support, the loss or gain of a relationship,
personality characteristics, personality characteristics and ability to work were all cited as
issues that contributed the improvement. Clearly there are some qualitative issues with
this methodology, specifically the lack of a non-litigating group, which limit the
conclusions that can be drawn from the study. It does appear that a range of issues are
related to any improvement and that the monetary factor is only one element that may or
may not contribute to the secondary gain of the litigation.

Several researchers have suggested that while presentation at litigation is slightly more
than pre-litigation gradually litigants returned to the same behaviours as non-litigants.
Indeed Mendelson (1987) suggests that "the view that the prospect of financial gain is the
sole, or even the predominant factor that maintains chronic pain and disability is not
supported" (p. 710). When this was tested Mendelson (1984b) found that between 35%75% of litigants continue to attend for medical treatment and remain disabled when
interviewed 2-3 years after the litigation has concluded. The current research also seeks
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to find different responses from former litigants to those without litigation experience to
assess whether the litigation experience has an impact on malingering.

The existence of any change in pre and post litigation injury levels has been described
(rather than explained) through the use of such terms as functional overlay, litigation
response syndrome and compensation neurosis (Mendelson, 1992; Main & Spanswick,
1995; Lees-Haley, 1988). While debate rages over the empirical validity of this
'diagnosis' within Australian courts this has been accepted as a legitimate concept (i.e
Kilpatrick v The Commonwealth Bank of Australia (1988) N82/156 Administrative
Appeals Tribunal). With regards to litigation response syndrome Lee-Haley (1988)
indicates that a series of symptoms such as depression and anxiety arise from the process
of being personally involved in litigation that may hinder either defendants or plantiffs in
their ability to protect their interests. One of these responses Lees-Haley (1988) suggests
from his clinical experience is hysterical and hypochondrical responses in which
symptoms may be exaggerated in number or degree. He does suggest that this
exaggeration should pass at the conclusion of the litigation suggesting that the effect of
litigation on chronic pain, is at best temporary.

7he ef("ect of" litigation on the level of exaggeration of chronic pain patients

While treatment outcome does not appear to be affected by Iitigation, the mere
involvement with the legal system appears to suggest that litigants are 'tainted' as they
are more prone to exaggeration of their complaints for external gain. As was mentioned
earlier, Mendelson (1987) assessed chronic pain patients of which 157 were receiving
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compensation or had been involved in litigation and 106 had no entitlement to
compensation. It was found that there was no significant difference between litigants and
non-litigants on the Conscious Exaggeration Scale (as Clayer et al., 1984 used). This
suggests, that litigants as opposed to non-litigants, are no more likely to be exaggerating.
This appears contrary to some of the suspicions in relation to the assessment of pain
(DSM IV, J994; Faust, 1995).

Conclusion
Clearly the effect of litigation on both reported pain and malingering has been either
explicitly or implicitly addressed both in assumptions made in assessment and in
research. It has to be said, that currently there does not appear to be an effect on either
the ability to malinger or on the level of reported pain according to the research however
clinicians continue to believe otherwise. Whilst most assessment tools state that litigation
is a crucial element in malingering, it could be said that its presence does not increase the
likelihood, only that the reasons for external gain, are more clearly defined. Regardless
of this, when a change in pain levels does occur, it could be due to stress in the litigating
process rather than malingering, when no statement of intent exists. As this element of
the study is yet to gain clear direction, the resulting hypothesis will be positive rather than
negative, to assess whether a relationship exists at all.
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Validation of Malingering Detection Scale by the author
Methodological Issues in Research

In this section the issues arising from the development and validation of the Barkemeyer
Calion Jones Malingering Detection Scale are discussed with reference to the major
issues in malingering research. Specifically the lack of internal validity in the
development of the MDS is discussed and the attempt by the current research to redress
this imbalance by using a combination of a known groups and simulation design is
detailed. The issues arising from this approach are then discussed.

111e development of the Barkemeyer Callon Jones Malingering Detection Scale

The Barkemeyer Calion Jones Malingering Detection Scale (MDS) is based on 26
malingering behaviours (Sec Appendix 1) that the authors have identified (Barkemeyer,
personal communication) (Appendix 4). Their method of identifying specific
malingering behaviour appears to come from clinical experience as no studies or pilot
testing are discussed in either the paper by Calion, Jones, Barkemeyer & Brantley (1989)
or in the manual for the MDS. Such experience may have come from Barkemeyer and
Calion as they have extensive experience in neurology and behavioural neurology
respectively. These 26 malingering behaviours represent 26 items in the scale while the
remaining 3 examine the goals of such behaviour. Hence the MDS has a total of 29
items, an interviewee is given one point, for each behaviour or goal that they exhibits
during the interview.
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Original validation study
In the original validation study (Barkemeyer et al., 1989) a known groups design was
employed in which external methods were utilised to define who was a malingerer and
then the MDS was used to test whether the same individuals were identified. In this case
it was one neurologist who made his/her judgements using an unstated criterion. Using
this approach it was stated that the MDS was developed to "differentiate between patients
who are malingering and those who have a recognisable organic disease" (Calion et al.,
1989, p. 3). Furthermore the MDS attempts to provide a clinician with "positive
inclusive evidence" (p. 3) that a patient is malingering whereas a conclusion that a patient
is malingering is reached more frequently on the basis of exclusion evidence rather than
direct evidence. The purpose of the original validation study (Calion et al., 1989) was to
test the hypothesis that the test differentiates between "patients whose medical complaints
were associated with physical evidence and those who were determined to be
malingering"(p. 4). As Smith ( !997) notes no demographic data was provided on the
participants, which makes the effectiveness of the scale difficult to judge, as other
features may be responsible for certain individuals being selected, and not just their
behaviour that indicated malingering.

Research by Barkemeyer et al. (1989) indicated that the scale had high internal
consistency (alpha coefficient of .93) and inter:rater reliability (r = .94). Predictive
validity (r=.86), which is what the current study is primarily concerned with, was
assessed by a criterion measure. This measure according to Call on et al. (1989) was
designed to reflect a lack of cohesiveness in the patient's responses and the absence of
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objective findings supporting the complaints. Specifically, the criterion score was
derived from three items: the presenting complaints were not consistent with a defined
symptom complex, the neurological examination failed to support the patient's
complaints and laboratory test results were equivocal or did not support the patient's
behaviour.

A hoard certified neurologist was used by Barkemeycr ct al. (1989) to examine 122 adult
neurology clinic patients, and to give a criterion score out of three using the criterion
approach previously outlined. If the criterion was either two or three, the patient was
considered to be malingering. Under this system 30 of the neurology patients were
considered to be malingering while the remaining 92 were considered to be nonmalingerers. When the MDS scale was applied it was found that the mean score for nonmalingerers was only 1.3 out of 29 compared to the mean for the malingerers (13.87).
This, Calion et al. (1989) suggests, is due to "the suspect behaviours tend(ing) to
characterise the presentation of the malingerers" (p. 5). A discriminant function analysis
indicated that a score of 7.6 differentiated between malingerers and non-malingerers.
Finally a cross classification procedure was completed which showed that the MDS
correctly identified 95% of patients as being in the same group that the criterion measure
did.

Cross validation study
A cross validation study, discussed by Calion et al. (1989), was completed later using a
completely different sample group of 66 neurology clinic patients and a non-neurologist.

Validation of the MDS

57

The evaluator, who had some knowledge of neurology was either a medical resident on
neurology rotation or was an experienced neurology nurse. An MDS was completed by
the evaluator. A neurologist, blind to the evaluator's ratings, classified each of the
patients as either malingering or not malingering. Barkemeyer et al. (1989) research
indicated that an MDS score of 7-8 to differentiate between malingering and nonmalingering was use in this study. A person who scored 7 or less was judged to be not
malingering however a person who scored 8 or over was judged to be malingering.
When the results were compared to the neurologist's assessment it was found that of the
patients who scored 7 or less, 100% had been judged as not malingering. Of those who
scored 8 or over, 94% had been judged by the neurologist as malingering. One person
whose MDS score was below 7 was judged by the neurologist to be malingering.

Smith (1997) is only authority other than the authors to provide a substantial critique of
the MDS but he tends to only note the similarity or originality of the different sections of
the MDS rather than directly assessing its validity. Four points were made by Smith

(J 997). First, the development of the scale, specifically the basis of the items, was not
clear. Second, the validation studies conducted by the authors of the scale did not supply
any demographic information, which makes it difficult to directly assume that it was not
features other than malingering, which caused this result. Third, the validity procedure
was flawed as there was enormous potential for contamination of results, between
predictors and criteria. Finally, Smith ( 1997) notes that research with additional
populations is needed to determine the scales generalizability. Clearly the present study
is part of this process as no validity study has been completed for the MDS and chronic
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pain, despite Hall and Pritchard's (1996) assertion that the tool was to be used for
assessing malingering in pain populations.

Reliance on expert's opinion
The issue that Smith (1997) highlights is the reliance on an expert's opinion. Further to
this Clayer, Bookless-Pratz and Ross (1986) in exploring this problem with pain found
that when two assessors (experienced psychiatrists) were asked to give a judgment of
malingering they gained an overall correlation of .64 with the conscious exaggeration
scale; developed in an earlier study (Ciayer.et al., 1985). This may suggest that the
correlations between experts may be improved, but only when an instrument is employed.
However in the validation of the instrument, it may be more beneficial to have a
simulation design once a knuwn groups design has been completed. Probably the worst
example of this bias in malingering research is from Leavitt's (1991) research in which
he validated his low back pain simulation scale by assessing a group of pain patients and
then indicating that the scale had identified the same individuals that he had, who were
suspected of malingering. The problem in this case being, that both the scale and Leavitt
(1991) could be assessing something completely different to malingering. Calion et al.
( 1989) at least utilised another neurologist to indicate those he considered likely to be
malingering making the MDS at least valid against the opinion of another professional in
the field. However if the prior findings of clinicians' dnbious ability to assess
malingering are taken into account then it is inappropriate that an instrument is assessed
against a clinician as opposed to another instrument known to be effective. The difficulty
being that no such instrument exists for chronic pain yet due to the reliance on patients'

Validation of the MDS

59

self report. What is certain is that the clinician used to denote malingering should not be
a senior author of the assessment tool, which is what Smith (1997) claims occurs in the
validation procedure.

Jutemal validity versus extemal Falidity
The current validation process will see the suggestion by Rogers (1997) that the measures
of malingering should be validated with a combination of simulation design and known
groups design being implemented. It is suggested in Rogers and Cruise (1998) that it is
the convergence of the two methods that "offers the strongest evidence of accurate
determinations because of their respective strengths: simulation design (internal validity)
and known groups comparison (external validity)" (p. 281). Through having all
participants with chronic low back pain, both of these elements are addressed because the
only difference between a known group and simulation when all the participants have the
same condition is the intent. In this case, this intent (workers' compensation lump sum)
is not only given to participants but any prior experience participants may have had just is
to an extent controlled by the usage of both litigants and non-litigants. So prior
experience of compensation may make a participant more aware or more cynical of the
potential for gain in such a system, which in turn, may regulate the strength of their
intent.

Interestingly, the Barkemeyer Calion Jones Malingering Detection Scale was developed
from clinical observations and essentially evaluated in the same manner, thereby losing
internal validity. In contrast, Rogers (1997) states that any measures developed from
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analogue research should then be cross validated with actual malingerers to gain external
validity. As Brena and Chapman (1995) noted, malingerers by definition do not identify
themselves, making a known group not feasible. The only possible group, would he
malingerers who admit, without duress, that they were attempting to fake or exaggerate
their symptoms, after the assessment procedure, thereby allowing the assessor to be
completely blind to the deception. This would be an interesting follow up for the current
research. Even malingerers who are 'caught', especially those with pain, have a myriad
of 'disorders' they can be diagnosed with, if it cannot be shown whether the deception
was conscious or unconscious. The decision in Boyd v General Industries (1987 as cited
in Hall & Pritchard, 1996) in which an employee was found to be malingering back pain
in a compensation claim, and the court ruled that the company pay for the treatment of
the issues that lead to her malingering, indicates that possibly American courts advocate
such an approach.

ls it malingering?
The difficulty with malingering research, as other studies such as Chapman and Brena
(1995) indicated, is that despite a wide range of possible criteria, it is still impossible to
conclusively separate individuals malingering from those showing abnormal illness
behaviour. Pillowsky (1994), the major writer in the abnormal illness behaviour field,
indicated he does not consider these two areas s'imilar at all, and was very angry that
elements of the instrument he developed, the Illness Behaviour Questionnaire, were used
by Clayer et al. (1984) to distinguish simulating malingerers from control pain patients.
Given this, it appears virtually impossible to define criteria for deciding who is a 'known'
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malingerer, for those with chronic low back pain without a very specific statement of
intent. It does appear possible to have a known groups design when validating instrument
such as the SIRS (Structured Interview of Reported Symptoms) (Rogers, Gillis, Dickens
& Bagby, 1991) because they are designed specifically to address discrete variables

within psychiatric disorders. Pain is so multidimensional that currently this level of
discrimination does not appear possible.

Simulation designs
There are several issues with simulation designs which make them much easier to
experiment with, but most have problems with external validity. Rogers and Cavanaugh
(1983) have indicated that the responses used in such validation studies are obtained by
asking participants to simulate malingering in order to study 'true' malingerers. This,
they suggest represents a paradox in asking participants to comply to instructions to fake
in order to study participants who fake when asked to comply. Similar to this point
Rogers, Cruise and Sewell (as cited in Rogers, 1997) noted the importance of very
specific instructions to fake in which a stated goal must be made, rather than simply to
'try to fake'. Indeed Leavitt's ( 1985) instruction to try to play the role of a person trying
to convince their doctor that they have severe back pain, is clearly not enough
information. Rogers et al. (as cited in Rogers, 1997) suggest 6 elements be present in
any instruction to malinger: comprehensibility, specificity, contextuality, relevance,
motivation and believability.

These have been incorporated into instructions to

participants for the current research as much as possible.
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Conclusion
The original development and validation of the Barkemeyer Call on Jones Malingering
Detection Scale was lacking in internal validity, and so it is appropriate to complete a
well controlled simulation design on this scale. This will strictly control the concept of
intent, so the techniques used to simulate malingering will represent, to some degree, a
known groups design. Specifically, a person already suffering chronic low back pain
rather than someone with no experience of the problem is asked to exaggerate.

Pm·pose of the study

Call on et al. (1989) suggests that the Barkemeyer Calion Jones Malingering Detection
Scale represents "a standardised means for organising one's observations of patient
behaviour. .it provides a systematic aid to decision (making)"(p. 6). This study seeks to
verify that the MDS can distinguish between people with chronic low back pain who are
exaggerating their symptoms and those who are being as honest as possible. In addition,
this study seeks to assess whether, as some clinicians appear to believe, litigation is a
fundamental basis for suspecting malingering in a chronic low back pain patient (Long,
1986; Mensana Pain Clinic, 1997; Leavitt & Sweet, 1986).

Limitations

This study has several limitations both general to malingering research and specific to
this study. Faust (1995) outlines several limitations in most malingering research. These
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are a restriction of information to clinicians and a failure to warn clinicians about the
possibility of malingering. The current research addresses this by conducting an
interview, in which questions can be actively asked by the clinician and the purpose of
the interview is for a pain evaluation which directly impacts on an external system.
Therefore, the possibility of malingering should also be assessed, albeit briefly, by an
evaluator hence the purpose of the study. Hall and Pritchard (1996) suggest that
involuntary malingering makes simulation designs obsolete, as this form of design
presumes intent, as does the legal definition of malingering. However the present study
seeks to closely focus on the scenario invalving external rewards which Rogers et al. (as
cited in Rogers, 1997) suggested, thereby focusing on conscious malingering. In this
sense the study rejects the construct of unconscious or involuntary malingering, as a
specific goal behaviour or intent must be expressed in some form, by definition, for
malingering to occur.

Along a similar vein, recent research by Rogers and Cruise (1998) has found that when
external incentives are provided for successful malingering and punishments for
unsuccessful malingering are also included, the quality of malingering rises. This study
does not provide incentives for either a negative or positive nature. In addition while
positive incentives are relatively clear it must be questioned what form the negative
incentives might take (perhaps fraud) given the liberal use of terms such as functional
overlay and compensation neurosis which are still so commonly applied (Mendelson,
1992; Main & Spanswick, 1995). In Rogers and Cruise's (1998) research participants
(students) were asked to asked to malinger a major depression for positive incentives
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(class credit and possible financial reward) or negative incentives (loss of class credit and
public posting of unsatisfactory performance). The results indicated that participants
with negative consequences were more focused in their feigning than those with positive
incentives and produced fewer symptoms unrelated to depression. The implications that
Rogers and Cruise (1998) posit that came from this study (simulation design) was that
incentives should are offered for both successful and unsuccessful malingering, both
negative and positive incentives should be offered, the contexts used are relevant to the
participants and germane to the psycholegal issue, and the groups assessed should be
representative of the population to which such a forensic evaluation would be applied.

The final issue with this research is the lack of generalisability and lack of control over
the condition of the participants. This study is really only generalisable to men who are
claiming to suffer from chronic low back pain. Furthermore while this study went to
some effort to only have participants with chronic low back pain, the respective condition
of that patient was not controlled for. This was on two levels: level of injury/loss of
function and medication. No attempt was made to ask the level of injury to the back prior
to participating in the study. Second, no record of substance use when completing pain
evaluation tasks was made. The effect that this would have on this study is unknown.
This does reflect Smith's (1997) call for more studies validating the MDS with different
populations. In this case the population is very specific but given the use of men aged
from early to middle adulthood (Greene, 1997) with chronic low back pain (Long, 1986),
represent two groups upon which considerable suspicion is placed on regarding
malingering.
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Design of the current study

The validation work by Barkemeyer et al. (1989) using a known groups design parallels
the work by Chapman and Brena ( 1995) in which an expert's opinion is used to denote
who is malingering and. This, in a sense, is circular because the tool is designed to be
independent of the expert, and should be validated against another criteria with more
objective evidence. Even the use of private investigators would be difficult given the
discussion by Waddell and Turk (1992) on-chronic low back pain which suggests that the
loss of function can alter over time, and that some behaviours while not possible some
days are possible on others. Similarly, functional testing, as was suggested by Waikar et
al. (1991), may also have similar difficulties as the level of pain may bave little to do
with the functional capacity and as Bigler (as cited in Bourg, Connor & Landis, 1995)
has mentioned the test for malingering should involve motivation rather than physical
ability. The Barkemeyer-Callon-Jones Malingering Detection Scale does appear to assess
this at some level.

Hypotheses
On the basis of the literature, six hypotheses have been generated to accurately determine
whether the Barkemeyer Calion Jones Malingering Detection Scale is capable of
differentiating between participants, all of whom suffer from chronic low back pain, half
of whom are asked to malinger while the other half are asked to be honest. How and
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where the scale is most successful will be examined, as will potential correlates such as
previous experience with litigation and level of reported pain.

I. The scores on the Barkemeyer-Callon-Jones Malingering Detection Scale will be
significantly higher for those asked to malinger than those asked not to malinger.
2. The criterion of a score of 7.6 on the Barkemeyer Calion Jones Malingering Detection
Scale will differentiate, to a significant level, those participants asked to malinger,
from those not asked to malinger.
3. The items on the Barkemeyer Calion Jones Malingering Detection Scale that will
differentiate those asked to malinger from those asked not to, will be items 4 and 5
which focus on severity of the problem rather than description and part two of the
scale in which the potential gains or benefits derived from the pain are examined.
4. There will be a significant relationship between scores on the MDS and reported level
of pain.
5. Participants who are former litigants will have significantly higher scores on the
Barkemeyer Calion Jones Malingering Detection Scale than those with no prior
litigation experience regardless of whether they are asked to malinger or not.
6. Participants with previous experience in litigation will have significantly higher levels
of reported pain than those with no prior litigation experience regardless of whether
or not they were asked to malinger or not.
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Method

Participants

There were 32 participants in this study, all of whom were men who had suffered chronic
low back pain (3 months or longer). This criteria was made on the basis of the Western
Australian Work Cover Authority's demarcation of 3 months after the injury, as most low
back injuries heal within this time. Most participants were well within the standard
criteria of 6 months suggested by the DSM IV (1994) and Turk and Melzack (1992). The
average length of time that back pain was suffered was in fact 124 months with only two
participants having pain for less than 6 months.

Although all participants were male chronic low back pain sufferers, the sample was
drawn from a number of different sources but overall could be characterised as a
convenience sample. Specifically, it included 13 serving officers from the Western
Australia Police Service, 14 members of the community and 5 former clients of a pain
centre in Perth. Initially, it was thought that all the participants could be recruited from
the pain clinic, however there were not the number of willing participants available. This
was primarily due to the specific focus on both gender and type of chronic pain (i.e. male
and chronic low back pain). The aetiologies of the back pain were not controlled for and
involved pathological, mechanical and traumatic diagnoses. All the participants had been
involved in contact sports at some time which satisfied the issue of background of the
pain sufferer (Hargraves, 1996; Ryan & Kovack, I966). The age range of the participants
was 19 to 57 years of age with a mean of 40.5 (SD = 10.15).
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Of the 32 participants, I 6 were chosen as having been involved in litigation as a result of
their pain while the other I 6 had not. The method used to differentiate litigation from not
litigation followed a method similar to Mendelson's (1987) research. This involvement
in the legal system may have been only transitory, as often occurs in the workers'
compensation system, or it may have involved complex common law litigation
proceedings spanning years. Primarily this litigation group comprised individuals, who
received workers' compensation for their injury or compensation for motor vehicle
accidents. It is unknown whether the claim was made under common law, prior to nofault schemes being introduced, or was unrelated to either workers' compensation or
vehicle accident. The type of compensation procedure varied with the type of
employment. Some had involved lawyers directly while others had not.

The non litigation group comprised 16 participants suffering from chronic low back pain,
who by their own report had no contact with the legal system with reference to their pain.
The reasons why they did not enter into litigation varied, and were not explored by the
researcher. Within this group, it was deemed acceptable if they had contact with the legal
system for criminal matters, provided there was not an issue where feigning illness or
disability would have lead to a reduction in the charge.

Tools
Two scales were used, the Barkemeyer Calion Jones Malingering Detection Scale (See
Appendix 1) and a 50 point Numeric Rating Scale for pain intensity (See Appendix 5). In
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addition, participants were given directions to 'malinger' (See Appendix 6) or 'not
malinger' (See Appendix 7).

Barkemeyer Callon.Tones Malingering Detection Scale.
The Barkemeyer Calion Jones Detection Scale (MDS) (Barkemeyer eta!., 1989)
consisted of 29 items designed to assess malingering in neurology patients. It has been
suggested b'y Barkemeyer et al. ( 1989), Cunni en (1997) and Hall and Pritchard (1996) as
a useful assessment tool for assessing malingering in medical settings. lt is basically a
series of behaviours that an assessor should look for during the course of a routine
examination. Until now it has not been systematically evaluated by any group except the
authors.

The scale is in two parts. The first part examines specific behaviour or responses of the
interviewee during the interview while the second part examines the goals of the
interviewee.

Within the first part there are six phases: the introductory phase, history

taking phase (Characteristics of the Patient's presentation), history taking phase
(Manipulation attempts), patient's response to questions, examination phase and patient's
response to disagreement. These phases will be described in more detail later. The
second part does not have these phases and requires the examiner to specifically ask three
.

questions which assess what the goals for the patient's behaviour are.

The 'Introductory Phase' has three items listed, which are to be judged from the
spontaneous comments by the patient. These involve expressions of exaggerated
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confidence in the examiner's ability, statements designed to enhance his/her position in
society and statements denigrating those in the immediate community. The first 'History
Taking Phase' has 9 items which the interviewer uses to assess the patient's; focus on the
severity of the problem, focus on the impairment from the pain, exploration of alternative
aetiologies, use of non-causally based associations, unusual responses to treatment
(became worse or showed no improvement at all), denial of responsibility for clearly
voluntary acts and his/her presentation included a constellation of inconstant complaints.
In addition if the patient's disability was emphasised during the examination to the
exclusion of any consideration of his/her abilities, where the interviewee makes no
attempt to describe his/her strengths; only the impairment from the injury.

The second 'History Taking Phase' looks at attempts of manipulation by the patient, and
covers five items, although these items actually assess seven behaviours. These
behaviours involve citing another professional who agreed there was problem, describing
the prestige of others who allegedly found a pathological process, quoting an authority on
the suspected pathological process, using an irrational analogy to justify a claim of
physical pathology, threatening to harm self or others if relief is not found, overstating
the examiner's authority for intervening on the patient's behalf and making an
implication that there might he legal retaliation for missed diagnosis or improper care.

The 'Patient's Response to Questions' is examined for two behaviours. The first is
whether or not the patient questions the competence of the examiner to avoid answering
questions as he/she is unsure of the answer. The second is whether or not the patient

Validation of the MDS

71

gives an affirmative response to an inappropriate leading question, due to a lack of insight
into the alleged illness or impairment.

The 'Examination Phase' is the only area in the MDS where some physiological
knowledge is necessary. Two behaviours are looked for. The first is whether any
physical effort whatsoever resulted in an enhancement of the patient's presentation of
symptoms. The second is whether or not the patient's responses during the examination
supported a physiological explanation.

Finally, the 'Patient's Response to Disagreement' is assessed by looking for the presence
of three behaviours. The first behaviour is when the patient's response to the examiner's
explanation suggests a distorted meaning of the examiner's statement. This is often used
as a mechanism to avoid the acceptance of the examiner's explanation. The second
behaviour occurs when a patient demands a prognosis based on inadequate data, knowing
that level of information is insufficient to give an explanation. An examiner who obliges
this request places him/herself in an unjustifiable position. The final behaviour is
whether the patient questions the examiner's motives. Again this is sometimes used to
avoid acceptance of the examiner's impression.

The second part of the MDS assesses the apparent goals for the patient's behaviour. This
involves three elements. These clements assess whether the patient's complaints lead to;
the avoidance of a normal responsibility or noxious activity, the gain of either a concrete
entity or abstract quality and the retention of either a concrete entity or abstract quality.
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The MDS was then placed in an interview format (Appendix 8) which involved phrasing
appropriate questions to ask the participant. This was done for consistency in approach
between participants. The process that saw the scale placed into an interview format
involved writing item specific questions, drawing from the description and intention of
each item, as stated in the MDS manual. These items were then piloted with on a male
chronic low back pain sufferer, who is also a graduate level psychology student. Items
that were confusing, or inappropriate were altered. This individual was not a participant
in the experiment. The only issue being that questions were asked rather than comments
(i.e manipulation attempts) volunteered or attempted by participants as opposed to a
genuine physical assessment.

50 point Numeric Rating Scale of Pain Intensity.
The second scale used is a numeric rating scale for pain (NRS) similar to the one outlined
in Leavitt (1985) and Turk and Melzack (1992). This scale lists numbers in
chronological order from 0 to 50. Pain description statements suggests, that 0 represents
"No Pain" while 50 represents "Pain is Unbearable".

Direction to 'Malinger' or 'Not Malinger'.
The direction to malinger was problematic as it had to be very specific. Having
considered the instructions given by Clayer et al. (1984) and Leavitt (1985) it was
decided that both were inappropriate as they were designed for controls not people in
pain. An alternative direction was written with the help of the clinical psychologist (See
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Appendix 6, 7). This approach also satisfied all of the criteria specified by Rogers, Cruise
and Sewell (as cited in Rogers, 1997) of comprehensibility, specificity, contextuality,
relevance, motivation and believability.

The directions to malinger or not malinger was piloted on 4 individuals, all of whom had
chronic low back pain. When asked directly how they would approach an interview
having received these instructions, they said that they would alter their presentation in an
attempt to gain more compensation, compared to if they had not received any instruction
or an instruction to be genuine. Similarly, they clearly understood the direction to not
malinger. For the pilot and participants recruited from the pain clinic the direction to
malinger or not malinger was sent out as part of a letter but the other participants received
the direction on an instruction sheet. The content was not altered at all (See Appendix 9).

Procedure
Ethical approval was received from Edith Cowan University Psychology Department's
Research Ethics committee after they considered a proposal for the research.

The direction to malinger and not malinger, the pain evaluation and MDS interview were
piloted and modified where necessary. This also provided practice for the researcher in
the practical aspects of the study.

There were two methods by which participants were recruited. The reason that the
community and police sample was involved was that due to a lack of willing research
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participants from the pain clinic it was necessary to find an alternative source of men
suffering from chronic low back pain. The former clients of a pain clinic were recruited
through the clinic whereas the community and police sample were recruited through a
slightly different method, described below.

Participants from/he pain clinic
Initially it was hoped that all the participants could be generated from a sample of former
pain patients treated by local clinical psychologist, who has worked in the field of pain
for some time. He provided the names and phone numbers of 88 former patients from
his practice. All of these former people were men, who were over 18 years old and
suffered from chronic low back pain. All of these men had suffered from this pain for
over 2 years.

Of this total of 88 patients, 42 had previously been involved in litigation while the
remainder had not. The definition of litigation involved any contact with the legal
profession as a direct result of pain. Generally the litigation involved motor vehicle
accident compensation or workers' compensation.

These two groups were to be generated through contacting patients in the pool and asking
whether they would agree to be part of the research. This followed a strict set of criteria
for the phone call (See Appendix 10). People were told that the interview would take
approximately 20 minutes and then I 0 minutes for debriefing. If the person called agreed
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to participate an interview was scheduled. All the interviews were conducted either at the
participant's home or workplace.

During this phone conversation the former pain clinic clients who agreed to participate
were told that they would receive a package in the mail that would contain:

• a letter indicating whether they were to pretend to malinger or not malinger
•

5 numeric rating scales, one for each day prior to the interview. They were asked to
fill these out in accordance with their orientation of either 'malingering' or 'not
malingering' but not until after the interview was completed

•

a letter from the psychologist introducing the research and giving his support to it
was also included (See Appendix 11)

•

a comprehensive informed consent form was given, with pertinent phone numbers
and a tear off consent section indicating that the participants had read and understood
the purpose of the study (Appendix 12). This was to be signed and returned at the
interview

•

a reminder sheet was given listing the time and date of interview to avoid confusion
(Appendix 13).

Participants were assigned to the 'malinger' or 'not malinger' orientation by a third party.
This was achieved by the third party placing the letter in and then sealing the pack. The
packages were arranged in such a way that half of each group had been involved in
litigation. This package was then posted. The address was kept by the assessor for the
interview, but this was destroyed immediately after as was the name of the participant to

Validation of the MDS

76

avoid identification. A system of code numbers was generated to avoid the use of names
and increase confidentiality. The only use of names for the remainder of the study was
for the informed consent forms which were kept separately from the data in a locked
room. These gave no indication of whether the participant had previously been involved
in litigation and more importantly whether they were given an orientation of malingering
or not. This was done to protect individuals who may decide to litigate in the future from
any repercussions of being involved in a study which assessed their ability to malinger.
Prior to the interview, the participants were asked for their signed informed consent form
and then the interview begun.

Two participants withdrew from the assessment prior to the interview having received
their information pack containing an explanation of the research. Both noted that they
were ethically opposed to the assessment of malingering. They were thanked for their
time.

Community Sample and Police Sample
The participants from both the police and within the community were recruited through
word of mouth. The latter group was largely a convenience sample, where men were
simply asked by either the researcher's or an acquaintance's social and professional
'

contacts whether they suffered from chronic low back pain. If they indicated that they
did, they were asked whether they would be willing to participate in an experiment
looking at malingering and back pain. An interview time was then scheduled that was
convenient for them. They were then asked to indicate whether they had prior litigation
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experience when the definition was explained to them. As with former pain clinic clients,
it was stressed that if they intended to litigate, it was probably not appropriate for them to
participate due to the nature of the experiment (malingering). At this point their name
was passed on to the third party and placed in the appropriate category (litigating, nonlitigating). An envelope containing a direction to either malinger or not malinger was
placed in an envelope marked with their name by the third party. This envelope was
taken by the researcher to the interview in addition to five numeric rating scales for 5
days, an MDS, and an informed consent form.

Prior to the interview the researcher asked the participant to read and complete the
informed consent form. Participants could ask any questions about the research other
than those that might affect the outcome of the experiment. Next participants were asked
to open the envelope and read the instructions/directions to malinger or not malinger
without the researcher being able to see which set of instructions was being read. After
this, they placed the direction underneath their seat. They were asked if they understood
the instructions and the fact that this was an insurance assessment interview. All
answered in the affirmative. They were asked to complete the 5 numeric rating scales
over the next 5 days with reference to the direction they were given. The interview then
began.

The interview
The interviews were identical for all participants. They were generally conducted at the
participant's home or workplace. This was done for two reasons. The first being that as
many were in chronic pain, the necessity and cost of taking transport to participate in the
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study, seemed unfair and potentially unethical. The second being that in some cases, an
insurance assessor may come to the home and certainly workplace to discuss the claim,
and make certain decisions based on what he/she perceives to be occurring. Hence the
use of the home or workplace rather than a more formal environment seemed appropriate.

After introductions, it was made certain that the informed consent form was signed
correctly and that the participant was aware of the ramifications of this. Participants were
asked again, regardless of their sample group whether they understood the directions to
either malinger or not malinger.

The interview generally lasted 20 minutes, with both parties sitting facing each other. The
participant was asked a series of questions from the MDS, and if necessary clarification
was requested. Out of the view of the participant the researcher marked 1 or 0 beside
each behaviour (1 =behaviour exhibited, 0 =behaviour not exhibited). At the
completion of the interview, the participant was asked to return to the examiner the five
Numeric Rating Scales for pain severity within 10 days of the interview. In some cases
an addressed envelope was given to the participant. In most cases the NRS forms were
left at a mutually agreed place i.e. front desk, researcher's workplace, with acquaintance.

At this point the researcher asked the participants if they had any questions about the
study. These were answered in as much detail as possible. The interviewee was thanked
for his time and told that a summary sheet would be available if he wished to receive one.

Validation of the MDS

79

In this case, his address would be kept, until the results were completed after which they
would be posted to him, and then his address would be destroyed.

Concluding the collection of" data

When the required number of interviews were completed, there were four cells with 8
participants in each. These cells are: former litigating participants directed to malinger,
former litigating participants directed to not malinger, non-litigating participants directed
to malinger and non-litigating participants directed to not malinger. This gives a total of
32 participants. The third party notified the researcher when this condition was met and
the interviews stopped. Possible participants in each sample who had agreed to
participate were thanked for their preparedness to be part of the study.

The data were analysed using SPSS 7.5.
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Results

The data were analysed in three different ways and are reported in three sections. The
first assesses the stated hypotheses while the second assesses any possible interaction
effects through multivaritate analyses. The third assesses the effect of different methods
of generating participants and the effect this may have had on their subsequent MDS and
reported pain scores. The third level of analysis was necessary to judge the impact of the
convenience sample.

Where results for pain measures were missing (n=2), these were coded as missing. This
occurred for one member of the malingering group and one member from the nonmalingering group.

Hypotheses
The six hypotheses were assessed using a variety of statistical measures such as t-tests,
chi squares and general descriptive measures. These low level analyses are used because
the relative! y low number of participants in this study would violate the assumption of
homogeneity if multivariate analysis rather than a series oft-tests were completed.
Despite this, an analysis using an AN OVA procedure was completed for future research
possibilities, which is in line with Tabachinick' and Fidell's (1996) assertion that
multivariate analyses are with less than participants is non random samples does not
necessarily violate homogeniatity .. This is presented in the second area of the results
section.
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Hypothesis 1 which stated that the MDS scores would be significantly higher for those
participants directed to malinger than for those who are directed to be genuine, was tested
using a t-test. There was a significant difference on a two tailed test (.035, p<.05)
between those asked to malingerer (M = 7.37, SD = 3.09) and those asked to be as honest
as possible (M

=5.31, SD = 2.08).

As hypothesised those asked to malinger had

significantly higher scores on the MDS.

Hypothesis 2 which stated that the MDS score criterion for malingering (if a participant
scored over 7.6 he was considered to be malingering) would distinguish between
participants directed to malinger, and those directed to be genuine was tested using a chisquare procedure. Participants were classified as malingering (above 7.6 on the MDS
score) or not malingering (below) and this was compared with the instructions to
malinger or not malinger. A chi square was applied to the data to test the confidence with
which the MDS could be used to distinguish between those attempting to malinger and
those not.

Table 1
MDS designation of malingering/not malingering when compared to the direction to
malinger or not malinger (2 * 2 table)

Directed to be honest
MDS Score - Not
Malingering
MDS ScoreMalingering

Directed to malinger

15

9

1

7
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A goodness of fit test with d.f. = 1 gave a result of 5.12 which gives a significant positive
result (.025, p<.05). This result indicates that there is a significant fit between the
expected results of J 6 true positives and 16 true negatives compared to the results
presented in table 1. The reason for this significant result is found in the correct
classification rates. The correct classification rates for Table 1 are a true positive rate of
approximately 44% and a true negative rate of 94%. The false negative rate is 60% while
the false positive rate is approximately 6%: Clearly the significant goodness of fit is due
to the exceptionally high level of accurate classification of those participants asked not to
malinger. In fact the correct classification rate for those asked to malinger is less than
chance (44%). Minium, King and Bear (1993) suggest that when results are discrete (1 or
0) and the degree of freedom is 1 it is feasible to complete a one-tailed ANOVA. Despite
the low participant numbers this was completed and found a significant result (.013,
p<.05) in the between groups measure.

Hypothesis 3 predicts that the items of the MDS that will significantly differentiate those
directed to malinger from those directed to be genuine will be those focussing on severity
of injury rather than description of injury (items 4 and 5) and on the motivations for the
gain with the pain (part 2: items 27, 28, and 29). Due to the low number of participants it
is not feasible to complete a data reduction technique such as factor analysis and
therefore a descriptive form (graph) will be generated to show differences between those
directed to malinger and those directed to be as honest as possible. Each behaviour, as
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defined by the 29 behaviours in the MDS , is given either 1 or 0 by the researcher for each
participant. In the case of figure 1 the behaviours endorsed (given a 1) by the researcher
for each participants are displayed for both those asked to malinger and those asked to be
genuine.

Figure 1
Number of participants directed to malinger compared to those directed to not malinger
endorsed for each MDS item
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From this table it becomes clear that certain behaviours identified by the MDS were
exhibited for those asked to malinger more so than those asked not to. In addition,
certain behaviours noted by the MDS as indicative of malingering are endorsed for those
asked to be genuine at higher rates than those asked to malinger.

An examination of the different behaviours was completed utilising an arbitrary figure of
4 (or more) participants to separate the two groups for each MDS behaviour. Using this
arbitrary criteria an examination of the items where at least 4 more participants directed
to malinger than those asked directed to be honest exhibited the behaviour indicated by
the MDS item. These MDS items were: 1, 4, 5, 11, 12, 13 and 18. Those directed to be
honest had items 7 and 9 endorsed for 4 or more participants (asked not to malinger)
more than those directed to malinger. These items will not be described in detail on the
basis of comments by Ben-Porath (1994) and Berry et al. (1994) regarding the ethical
danger of publishing details of malingering detection techniques. This will be discussed
in more detail in the discussion.

[/ems endorsed j(n· more ( = >4) participants directed to malinger than not:
Item 1 related to the feelings associated with being assessed for pain, and that generally
they were not very positive about it.
Item 4 is the use of severity to describe the pain rather than an actual description of the
pam.
Item 5 is the catastrophising by the participants of the effect that the pain has had on your
life. The participant is asked whether they can think of an achievement they have had
since they have had the pain.
Item 11 represents the extreme percentages given when a participant is asked for a
percentage of normal behaviour that they can no longer do solely because of the pain, and
what new skills they have attempted to learn to compensate for abilities lost due to the
pain.
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Item 12 is a negative comment by the participant when he is asked whether he will be
able to learn new skills.
Item 13 relates to the negative comments made about medical practitioners with regards
to their treatment methods and general attitude towards the problem.
Item 18 represents the overstating of the examiner's ability to help the problem or to
intervene in the issue.

Items endorsed for more (=>4) participants directed to be honest rather than malinger:
Item 7 would ask for other explanations for why the pain might exist. To be endorsed
this was answered in the affirmative.
Item 9 asked for any voluntary behaviour that might exacerbate the pain.

If more participants were available a factor analysis could have been completed giving
more statistically pertinent results.

Hypothesis 4 predicts that there will be a significant correlation between MDS scores and
the level of pain intensity as assessed by the numeric rating scale (NRS). A bivariate
correlation was completed and found that there was no significant relationship between
the average level of pain and the score on the MDS using a Pearson Product Moment test
(r = .253). On the basis of this result a further analysis was completed when the MDS
labels a participant as a malinger. Using at-test on the pain average it will be assessed
whether those labelled by the test as malingerers reported significantly higher levels of
pain than those labelled non-malingerers. The major issue with this test is the disparate
numbers of those labelled as malingerers (8) compared to those labelled non-malingerers
(24). This assessment found that those labelled by the MDS to be malingering reported
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significantly (.20, p<.05) higher levels of pain on a two tailed test than those asked not to
malinger. The respective pain averages were 21.3 (SD

= 14.3) and 35.6 (SD = 9.5).

This does not necessarily answer the question regarding malingering per se, and so a
further analysis was conducted using at-test of the pain averages of participants asked to
malinger and those who were asked to be as honest. There was a significant difference
(.00, p<.05) between the mean reported level of pain for those asked to malinger (M =
35.08, SD = 8.3) and those asked to not malinger (M = 14.2, SD = 11.7). The respective
standard deviations were not wide enough to explain these results with the standard
deviation for both groups within 3 increments on the pain scale of each other. When
looking at differences in malingering this appears to be a stronger result than when
participants are labelled malingerers by the MDS. The reason being that the groups are
equal and the difference between the two groups is greater than that for people designated
by the MDS to be malingering or non-malingering.

Hypothesis 5 seeks to assess whether the experience of prior litigation will effect
participants' MDS scores by raising them significantly compared to those not previously
involved in litigation and regardless of whether they were asked to malinger or be honest.
A !-test was completed to assess the differences between former litigants and nonlitigants on scores on the MDS however no significant result was found (.578, p<.05).
This suggests that the experience of formerly having litigated did not appear to affect a
participant's score on the MDS. It is interesting to note that the average MDS mean score
was actually slightly higher for the participants who had not been previously involved in
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=2.6) compared to those who previously did have litigation

experience (M = 6.06, SD = 2.9). Therefore the hypothesis is rejected and the null
hypothesis is accepted that prior litigation does not appear to impact on MDS scores.

The final hypothesis predicts that participants who were previously involved in litigation
will show significantly higher levels of reported pain regardless of orientation
(malingering/non-malingering) compared to those who have not previously been involved
in litigation. A !-test was completed to assess whether litigation made a difference to the
level of reported pain and was found to be non-significant (.6, p<.OS). Interestingly, for
reported pain former litigants did report marginally more pain (M

=26.78, SD = 13.8)

than participants without any previous litigation (M = 23.91, SD = 15.2). In both cases
the standard deviation was relatively high (-14). This suggests that litigation is not
necessarily indicative of higher levels of pain and given the large variance in the standard
deviation clearly indicates that people respond in different ways suggesting that no direct
causal attributions can be made to litigation regarding pain or MDS scores.

Finally, an analysis was completed to assess whether there was a relationship between the
age of participants and their respective scores on the MDS or the pain rating scale. This
was not hypothesised however some authors (Hall & Pritchard, 1996) have indicated that
there may be some relationship between malingering and age while others have found no
relationship (Mendelson, 1987). A bivariate correlation was completed. The MDS
scores did not have a significant relationship with age (.447, 2-tailed Pearson product
moment correlation). The reported pain intensity scores were also not significantly

Validation of the MDS

88

correlated with age (.223, 2-tailed Pearson product moment correlation). Age of
participants does not appear to affect either score.

Multivariate Analyses

Two 2-way ANOVAs were completed to assess for any interaction effects that may occur
between the direction to malinger and former litigation. While some authors have
indicated that the size of the current sample is not large enough to support the
homogeneity of variance required for an ANOVA as previously mentioned Tabachinick
and Fidell 's (1996) indicated that this was not necessarily the case. It was considered
that for future research it was important to assess the possibility of such an interaction
existing for either MDS scores or reported pain. An AN OVA table will be used to
demonstrate the calculations.
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Table 2
AN OVA table for MDS scores with litigation (former litigant/non litigant) and
malingering (asked to malinger/not malinger) conditions

Process
Main
Effects

2Way
Interact

Effect

Sum of
Squares
Combined 36.5

Mean
Square
18.2

F

Sig.

2.5

.098

Malinger
Litigation
Malinger

34
2.5
3.7

34
2.5
3.7

4.6
.349
.552

.039 *
.559
.476

40.3
202.8
243.2

13.448
7.246
7.8

1.856

.16

*
Litigation

Model
Residual
Total

The results of this clearly indicate there is no interaction occurring, only a main effect for
individuals asked to malinger(*), as was indicated by the Hest (0.039, p<.05).

A second ANOVA was completed to assess for an interaction effect of malingering and
former litigation on reported pain.
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Table 3
ANOVA table for NRS scores of pain intensity with litigation (former litigant/non
litigant) and malingering (asked to malinger/not malinger) conditions

Process
Main
Effects

2 Way
Interact
Model
Residue
Total

Effect

Sum of
Squares
Combined 3319.6

Mean
Square
1659.8

F

Sig.

15.8

.00

Malinger
Litigation
Malinger
*
Litigation

3199.12
120.48
50.996

3199.12
120.48
50.996

30.47
1.148
.489

.00.
.294
.492

3439.2
2729.6
6168.8

1146.4
104.9
212.7

10.9

0

This table, too indicates that there is no main effect between litigation and malingering.
There is, as the t-test indicated a main effect(*) only for those asked to malinger (0.00,
p<0.05).

Overall these results suggest that litigation does not have an impact on either scores on a
malingering scale or on reported pain.
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The effect of drawing participants (men with chronic low back pain) from a variety of
populations

To test the possible effect of the sampling a comparison of each group was made on both
measures. This was done by averaging the results within each group, and not
withstanding the different sized groups or roles (former litigant or malinger/nonmalinger) a perspective can be gained of possible discrepancies on the basis of the
population from which the participants were drawn.
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Table 4
Summary table showing the number of participants. average NRS pain intensity and
average MDS score for each condition drawn from each of the sample groups

Sample

Condition

Number

NRS pain level

MDS score

Former Pain

Litigant/Mal

3

37.73

4

NonLit/Mal

1

42

7

Lit/Nmal

1

26.4

3

Litigant/Mal

3

26.7

9

Non Lit/Mal

5

30.24

8

Lit/Nmal

5

18.95

4.4

Litigant/Mal

2

45.1

7.5

NonLit/Mal

2

41

8.5

Lit/Nmal

2

11

9

11.11

5.25

Clinic Client

NonLit/Nmal
Police Sample

NonLit/Nmal
Community
Sample

c

NonLit/Nmal

8

92
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While direct comparison is difficult given the different sample sizes and the disparity
between the conditions it is clear that there may be some problems with deriving some
conclusions from this research. As the numbers and conditions of participants were not
controlled by population but rather by what was available some issues may arise which
will be discussed later. Clearly, there is substantial difference between the groups
however no one group appears to have altered the results of either the MDS or NRS pain
scores in any demonstrable way. The lack of participants from each sample present in
each condition makes conclusions difficult to draw regarding the conditions especially in
the case of non-litigating and malingering where only the participants drawn from the
community sample were used.

If the premise is supported that the use of different populations to draw the sample from
has an effect on the scores then this is clearly a problem however there appears to be a
wide range of responses, which is to be expected. As the goal of the experiment was
never to assess sample against sample, but rather chronic pain patients as a single group,
this breakdown was necessary only for the purpose of validation due to the change in
design. Indeed most experiments with pain patients (former or current) do not examine
the background of their patients this closely, especially when they have all come through
a pain clinic.
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Discussion

The results of this research through attempting to validate this assessment instrument
have, in some senses, generated more questions than they answer, which leaves fertile
areas for further research. There are some methodological deficits, however this research
has avoided most of the pitfalls of previous malingering research as suggested by Rogers
(1997). In fact, using the approach of all participants having suffered and therefore
having some knowledge and experience of the condition they are supposed to be
malingering, appears to be an excellent method of conducting research into malingering.
Some of theories propounded by the authors of the scale, the authors of the OSM lV and
clinicians in general, such as litigation being a significant correlate to malingering, have
not been supported by this research.

Overall while the MOS did appear to be able to discriminate between males suffering
chronic low back pain asked to malinger and those not attempting to malinger, there were
problems in the design involving severity of injury and sampling issues that prohibit
anything more than tentative support for the continuing use of the MOS. Specifically, the
fact that some items on the MOS, presumably designed to assess malingering, were
endorsed at much higher rates for those asked not to malinger raises particular issues for
some of the bases of the MOS. In addition, the scale does not appear to be useful at all
for detecting malingering as the name suggests but rather detecting those who are not
malingering. In this sense it is more useful as a broad screening tool, than providing any
form of diagnostic clarity. Clearly, much more research is needed with this tool, with a
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variety of populations and under very strictly controlled experimental conditions, before
it can be considered valid in any scientifically valid sense.

This chapter will address the hypotheses in the light of the results, methodological issues
encompassing conceptual and procedural issues arising from the study, implications of
the study, future research, and the conclusions that can be drawn from the study. Some of
the issues regarding the validity of assessing for malingering that were discussed in the
introduction are highlighted by the results of the validation of the MDS. These will be
canvassed as they arise.

Hypotheses
Three out of the six hypotheses appear to be supported.

First Hypothesis
The first hypothesis was supported as those men asked to malinger obtained significantly
higher scores on the MDS; higher scores being indicative of malingering according to the
system for scoring the MDS. Based on the results, the only reason for this higher score is
due to this group of participants trying to malinger. Another explanation could also be an
effect of the instructional set for malingering, therefore more research is needed that uses
different sets before it can be ascertained whaf exactly the MDS is finding.

Second Hypothesis
The second hypothesis supported the effectiveness of the criterion for malingering (MDS

Validation of the MDS

96

score of 7.6 and above) established by Calion, Jones, Barkemeyer and Brantley (1989).
The results found that the MDS could discriminate, to a significant level, between those
attempting to malinger and those who are not. This result is deceptive because it appears
that the scale was capable of pinpointing those who were asked to malinger, on closer
examination of hit rates, it becomes clear that the hit rate for labelling a malinger
accurately (true positive rate) was less than which would be achieved by chance. Instead
it is the true negative rate that clearly caused any significant relationship in which those
asked to be as honest as possible were correctly labelled close to 94% of the time.

The usefulness of this result over a true positive rate is important to recognise, for as
Mendelson and Mendelson (1993) observed malingering is not a diagnosis but rather it
represents a legal term. So a diagnosis cannot be substituted by malingering as an
alternative diagnosis. To further this logic when a diagnosis already exists, in this case a
high level of chronic low back pain, malingering may negate or lower the credibility of a
diagnosis but it cannot replace it.

If a participant's honesty or 'lack of malingering' can be substantiated then the original
diagnosis can be maintained. So patients complaining of chronic pain can have their
honesty regarding their chronic pain assessed and if their scores do not place them in the
malingering category then the diagnosis should remain. However, if patients return
MDS scores that place them in the malingering category, under the present results, it is
not possible to label them a malingerer with any degree of certainty (under chance).
Instead, it can be said that his/her results arc inconclusive and more collateral evidence is
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required. In many senses the ability of any scale to conclusively label an individual a
malingerer, given its legal definition, is highly suspect. Only comments stating his/her
presentation is inconsistent with present diagnosis or complaint can be made with any
degree of authority.

This logic is contrary to the American court decision of Boyd v General Industries (as
cited in Hall and Pritchard, 1996) in which the court conceded that the employee was
malingering her back injury but that the company would have to pay for her to be treated
for the problems causing her malingering. In this case malingering effectively replaced
the diagnosis because the court reasoned that because malingering was present there must
be psychological problems which needed to be 'treated'. The company defending the
case was responsible for that treatment.

Third Hypothesis
It is with the third hypothesis that many of the strengths and flaws of the MDS come to
light. This hypothesis was only partially supported. Certainly as hypothesised from the
comments and results from studies by Leavitt and Sweet (1986), Leavitt (1991), Clayer et
al. (1984), Hall and Pritchard (1996) and Rogers (1997) it did appear that individuals who
were attempting to malinger did show a tendency to focus on severity rather than
description of the pain and tended to catastrophise the effect of the pain on their life
(Items 4 and5). However, to give a definitive diagnosis of malingering and separate it
from abnormal illness behaviour, it was hypothesised that the participants asked to
malinger would have behaviours from part 2 endorsed. These behaviours involve

Validation of the MDS

98

admissions of intent or possible motives for exaggerating pain. Tbis was not supported
with an equal number of participants from each condition having this behaviour endorsed
for them.

Six MDS items were endorsed more for those asked to malinger than those asked to be
honest, two items were endorsed more for those asked to be honest than those asked to
malinger and one item was endorsed for both groups at an equal level (See Figure 1).
These differences were not hypothesised, however it is important to examine these
differences as it gives greater insight into the validity of the MDS. The decision to focus
on specific MDS items was made on an arbitrary basis by counting the number of
participants from malingering or non-malingering groups that each item was endorsed
for. Basically when an item was endorsed for 4 more participants in one group than the
other, it was commented on. This approach was used due to low participant numbers and
the subsequent inability to use data reduction techniques, that would have given
statistically sound arbitration points, such as factor analysis. Before an examination of
the items is made, it is important to recognise that the major strength of the methodology
employed in this study, is that as all participants have suffered chronic low back pain at
some time. This means that the cognitions that might be attributed to only chronic low
back pain sufferers cannot be used to explain the item endorsement.

llems endorsed more for those asked to malinger than those asked to be honest
The items that were endorsed more for those asked to malinger will be examined first and
possible reasons for this result will be given. The first item on the MDS (Item 1) was
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endorsed much more frequently for those asked to malinger and related to negative
feelings associated with being assessed for their pain. While not hypothesised, the high
level of endorsement of this item for those asked to malinger is in agreement with
research conducted by Peck, Fordyce and Black (1979) in their discussion of behaviours
commonly shown by individuals suspected of malingering.

The endorsement of item 11 was also not hypothesised but certainly contributed to the
significantly higher scores on the MDS for those asked to malinger than those asked to be
honest. This item involves an extreme percentage being given by participants when
asked what effect the pain has had in their life. An extreme result was generally
interpreted as 50% or greater which is clearly related to the catastrophising and overt
focus on the impact of the pain that items 4 and 5 assessed. The difficulty was that some
participants were clearly more injured than others. For example in several of the former
pain clinic clients, they were clearly relatively disabled compared to other chronic low
back pain sufferers.

An interesting item that goes towards assessing motivation is item 12 in which the
participant gives a negative comment when asked whether he will be able to learn new
skills and that he has not been trained in other areas. On one level this does appear to
indicate a disinterest in returning to former function and placing this responsibility on to
external factors which 'should' provide training; which some participants appeared to use
as a general approach to malingering. Another explanation can be derived from the
context in which the question is asked. This question follows on from an estimate of the
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percentage of behaviour that the participant can longer participate in solely due to his
pain, which would clearly impact on this question. It is not unreasonable to suggest that a
patient would be experiencing significant depression due to his chronic low back pain
(Mendelson, 1984a). The negative response that the MDS suggests is indicative of
malingering, could also represent depression.

The response to item 13 that separated those asked to malinger and those being honest
occurred when participants expressed very negative comments about medical staff whom
they had contact with regarding their pain.· While not an explanation for why those asked
to malinger were endorsed for this item, there is some evidence that often the medical
fraternity does not effectively treat low back pain. A survey of 1200 physicians by
Cherkin, De yo, Wheeler and Ciol ( 1995) found that while there was some consensus on
some techniques of treating chronic low back pain there was considerable disparity in
results. In addition, very few were recommending treatment that recent research has
confirmed as particularly effective suggesting that many physicians are simply not
specialised enough to provide treatment for their patients' chronic low back pain. It is
possible that those asked to malinger chose to focus on the negative experiences as a
method of discrediting further attempts by medical staff to assess their pain.

Finally, item 18 related to those asked to malinger, attempting to overstate the ability of
the examiner (researcher) to intervene on their behalf. This may well be a form of
manipulation on the part of the person playing the role of the malingerer as Barkemeyer
et al. (1989) suggest. He makes the assumption that genuine pain patients are sure that
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their pain will gain them the compensation, and regardless of who the insurance assessor
is, the truth of their claim will be won out. Malingerers are not as confident according to
Barkemeyer et al. (1989). Given this, if an individual is not as confident about his claim,
then he would probably tend to assume that if he could convince this one person from the
assessing body then he might be able to convince the entire body. It is difficult to explain
why this result appeared to as to differentiate between participants asked to malinger and
those who were asked to be honest, especially when there is prior experience of litigation.
It may be due to the experimental design, where a participant, especially one with little

knowledge of the insurance industry would assume that if they are told to malinger to the
examiner for external gain, then by implication the examiner must have some power in
the final decision for compensation.

Items endorsed more for those asked to he honest than those asked to malinger
There is some concern with the items that differentiated those asked to malinger and
those being honest with the latter group being endorsed more frequently for the
supposedly malingering behaviour than those asked to malinger. This suggests that the
item may be measuring something other than malingering. This is of considerable
concern as it could lead to false diagnosis, and it does suggest that this scale is not
effective in some areas of assessment for chronic low back pain. This occurred with two
items; 7 and 9.

Item 7 asked participants whether there were other explanations as to why the pain
existed and closely looked at whether there was a cause and effect relationship. While not
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apparent from the results there were several instances where the assumed aetiology of
accident or disease was simply not applicable and therefore, using the MDS criteria,
brings the client into suspicion. For example some individuals, even those being honest,
discussed different aetiologies for their pain, some of which were seemingly harmless i.e.
leaning through a car window, picking up a can of soft drink, turning over in bed. In
these cases the requirement for a specific cause and effect, is not fulfilled because it is not
unreasonable for the body to be able to perform the behaviour. In this sense the scale's
inadequacy was highlighted by the complete lack of causality sometimes in chronic low
back pain (FraudWatch, 1997). This item,.more than any other demonstrated the
importance of knowing about the condition that is supposedly being feigned rather than
having a strong understanding of malingering in general. In this instance the MDS is
perhaps not an appropriate tool for use with this condition.

Interestingly, item 9 related to individuals who voluntarily engaged in behaviour that they
knew would exacerbate the pain but were still prepared to engage in this behaviour. The
reasons for this varied from work to sport, however what became clear during the
interviews was that often people engaged in such behaviour to retain their self respect. ln
addition, what constituted a behaviour that would cause pain was strongly related to the
level of disability. One participant indicated that making a cup of tea caused him pain,
but he was prepared to go through pain to gain his stated goal. In contrast, participants
asked to malinger, may well have considered this question with some suspicion, and
deliberately answered in the negative, however there is no evidence to support this.
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Items where the level of endorsement was the same for both groups
Item LO called for several pain or numbness conditions physiologically unrelated to low
back pain to be suggested to participants as possible symptoms to test whether they
would falsely endorse symptoms. These were endorsed for both groups in equal levels.
Why this is important is that it is a technique that is widely used by medical practitioners
according to Cunni en (1997) and Hall and Pritchard (1996). This result, rather than
supporting this approach, suggests that it is problematic to suggest false symptoms to
individuals as a method of differentiating participants exaggerating their level of pain.
This is possible as the effect of chronic low back is so global (Mendelson, 1984a). This is
perhaps a more valid technique when assessing for malingered mental disorders, where
there is less awareness of symptomology in the community. Pain, as Lees-Haley (1986)
suggested, especially back pain, is widely experienced in the community (Haldeman,
1996) making its symptomology easier for malingerers to describe accurately.

Item endorsement in this study compared to prior research
The items endorsed on the MDS can be compared to the self reported items used in
Clayer et al. (1984), a study which also used a simulation design. There were three main
differences: the pain syndrome was not specified, individuals asked to malinger were not
asked their experience of chronic pain in the past and the items were derived from a
questionnaire designed to assess abnormal ilhiess behaviour rather than malingering.
There appears to be a focus on catastrophising and severity rather than description of
symptoms in the results of the current study, which does support Clayer et al.'s (1984)
findings. In addition, the distrust or dislike of the medical community was also apparent
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in the results of the current study, which supports some of Clayer et al.'s (1984) findings.
This suggests that certain factors may be present, which when asked to malinger, even
those with the experience of chronic pain, will still over-exaggerate to a significant level
rather than rely on subtlety. This was despite a warning in the instructions, to attempt to
be as subtle as possible.

Hypothesis 4
This hypothesis was not supported as the level of self reported pain was not significantly
correlated with scores on the MOS. Participants who were labelled as malingering by the
MDS had significantly higher levels of reported pain than those who were not labelled as
malingering. This was confounded by the disparity in participants found to be
malingering (n=8) compared to those labelled as not malingering (n=24). In addition,
those asked to malinger had significantly higher levels of pain than those asked to be
honest. Overall, these results suggest that, to an extent, there is a relationship between
reported pain and MDS scores, however with generally low MDS scores, this relationship
is not visible. Future research may be able to investigate this relationship further by not
asking pain patients to malinger, but rather asking all participants to be as honest as
possible. This may be feasible, once it can be conclusively shown the MDS can
differentiate between those asked to malinger and those asked to be honest, which this
study does suggest may be the case.

Hypotheses 5 and 6
Both hypotheses 5 and 6 were positive despite the research to the contrary as clinicians
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appeared to consider that litigation was indicative of malingering (Leavitt & Sweet,
1987). Each hypothesis respectively tested whether former litigants likely to have similar
scores on the MDS and levels of reported pain compared to non-litigants. As a collorary
to this an ANOVA was completed to assess any interaction effects between direction to
malinger and former litigation regarding both reported pain and scores on the MDS. The
MDS scores were not significantly different for former litigants and non-litigants, which
supports Mendelson's (1987) evaluation of the Conscious Exaggeration scale, as finding
no difference between former litigants and non-litigants. Both litigants and non-litigants
reported similar levels of pain which supports Mendelson's (1984a) findings. If
anything, there was a non-significant trend of non-litigants giving higher reported pain
scores than litigants. Neither AN OVA found any indication of an interaction effect
hetween litigation and the direction to malinger/not malinger.

It is important to note that this research specifically asked only men who had completed

litigation and did not express any desire to reinstate proceedings for their pain. This
differs from other research which has looked at pain levels before, during and after the
court case where results may be quite different. So while not the subject of this research,
this other research has shown that higher pain and anxiety levels have been shown in pain
patients during the court proceedings and are reduced but not eliminated once the
litigation is completed (Mendelson, 1992; Suter, 1998). It has been suggested as
evidence that individuals involved in litigation are more inclined to exaggerate their
symptoms for the benefit of the court. Both Mendelson (1992) and the promising
research by Suter (1998) has suggested that the issues pertaining to the court, cause
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anxiety levels to rise and in turn, this influences the level of pain. Litigation and pain
does not appear to be causally related despite appearing to have an association from
which no conclusion can be drawn.

Methodological Issues
As was indicated, there are several methodological issues which have made this study
difficult to generalise widely. These issues can be broken down into conceptual issues
and procedural issues. Conceptual issues are: the effect on the results of the population
from which participants are drawn, the lack of genuine financial incentive to malinger,
the lack of negative incentives that occur through failure and the loose definition of
litigation. Procedural issues are: changing procedures midway through research, the
difficulty in maintaining the blind condition of the researcher and participant numbers. It
should be said that these issues do not affect the data so much as to negate the results of
the research, that is, that the MDS did differentiate at a significant level between those
asked to malinger and those asked to be as honest as possible.

Conceplual Issues
The primary conceptual issue is the impact of the population from which the participants
were drawn. When this research was begun, it was not anticipated that there would be as
many problems gaining participants through th'e pain clinic as was ultimately
encountered. As a result, virtually no attempt was made to control for any impact made
by the different populations when dividing individuals into the different cells
(malinger/litigant, non-malinger/litigant, malinger/non-litigant & non-malinger/non-
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litigant). As a result the unlikely event has occurred where all 8 members of the nonmalinger/non-litigant cell were drawn from the community sample. This is conceptually
unsound and the very low pain rating compared to other groups does suggest that such a
difference may have been at least partially due to the population from which the
participants were drawn. Other participants drawn from this population appear to have
pain ratings and MDS scores around the same level as those participants from the same
conditions but drawn from different populations.

When the MDS scores and reported level of pain by police officers were examined it
appeared that police were not necessarily more prone to being deceptive than other
members of the population. It has been suggested by some writers that police, through
constantly interrogating individuals who often attempt to be deceptive(Trankell as cited
in Gudjonnson, 1992), probably learn quickly what works and what does not thereby
making them potentially very effective malingerers. This does not appear to be the case
with this sample.

Ideally, if the research had been completed as was originally planned, all the participants
would have been chronic low back pain patients treated by the same therapist. In this
sense there would have been more of a chance that the participants were genuine pain
patients. At the very least they would have already been assessed for treatment purposes
rather than relying, as the other groups do, on participants' self report. No screening test
for malingering was made prior to allowing participants into the study, but, as previously
mentioned, this would have been useful as a known groups design could then have been
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completed. However, if such a screening tool were available then there would be little
need for the current research except to assess construct validity.

There were two obvious differences between the 5 participants in the former pain clinic
client group and the remainder of the sample: only 2 of the 5 were working full time, and
3 of them had their lumber spine fused. Clearly this sample had more severe injuries than
those from the other sample. The usefulness of using extreme injury for a study into
malingering is questionable. For example in one extreme case one participant asked to
malinger stated "how could I exaggerate this, how could it be any worse than it already
is". In this sense, such participants were not necessarily the target group that this
research sought to examine. When this point is examined from an external validity
perspective, such participants would automatically be ruled out as malingerers because of
the willingness to have surgery and clear physiological damage as determined by
objective imaging instruments. There are exceptions to this, which will be discussed
later.

Overall, it must be said that the approach taken towards the sampling focussed on gaining
participants who fitted the criteria, and less attention was paid to where the population
came from provided they were male, suffered low back pain and had either had been
involved in litigation or had not. It did happen that due to the groups of police used
(traffic branch) many of the participants had been involved in compensation for vehicle
accidents whilst working. This lead to requiring more members of the community
sample who did not have a history of litigation to be used, thus in one cell only
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participants drawn from that group were included. It is interesting to note that the
Western Australian Police Service does not have any workers compensation
requirements, making vehicle accidents the only area where any form of compensation
will be paid. This may have altered the results, but there seems to be little evidence of
this in the results as they have heen analysed.

The commentary by Rogers (1997) and Rogers and Cruise (1998) regarding the need for
incentives (hath positive and negative) in malingering research is well taken. The
original design did incorporate some paym'ent for participation, but differential payment
for participants based on performance was deemed not acceptable by the ethics
committee at Edith Cowan University, Certainly any attempt to implement the negative
incentives that Rogers and Cruise (1998) suggested would be met by similar refusals.
Rogers and Cruise ( 1996) indicate that there are negative consequences for being
'discovered' exaggerating. Indeed, workers' compensation legislation in Western
Australia and Queensland both mention fraud or malingering as criminal offences under
the Act. However I would suggest that proving malingering, just utilising psychological
assessment would be very difficult when there are terms such as 'compensation neurosis'
and functional overlay that virtually allow you to have another illness (Main &
Spanswick, 1995) as opposed to your original diagnosis. The decision in Boyd v General
Industries (as cited in Hall & Pritchard, I 996) seems to indicate that an American court
had a similar opinion.

Regarding incentives to malinger, the present study, appeared to rely on 'dupers delight',
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a term coined by Ekman (as cited in Hall & Pritchard, 1996), to describe a sense of
achievement through 'tricking' an evaluator/evaluation. When the reasons for the
experiment were explained, the participants who had been given instructions to malinger,
often expressed an interest in 'how they went' and would jokingly ask how much they
could expect to get. With some men they expressed a sense of relief about being asked to
exaggerate, as often they had to be so careful and

und~rrate

their pain when being

assessed, for fear of being called a malingerer. These observations were made by the
author and have not been recorded in the data.

The definition of litigation was problematic, partly due to the presence of a 'no fault'
system (workers compensation & vehicle accidents) in place in which non-pecuniary
damages are not accepted, and this may have negated some of the original assumptions
regarding malingering, chronic pain and litigation. There were no participants with a
common law claim, although some participants went through substantial legal wrangling
with the insurance company before receiving any compensation. Guest and Drummond
(1992) have found that there is little difference between the two groups on most
measures, after the litigation has ceased, which is certainly the case with this study.
When this research started it was assumed that more participants would be involved in
common law claims rather just receiving treatment, lost wages and rehabilitation through
an insurer.

Part of the impetus of this research was to assess the potential impact of lawyers in
personal injury claims. Whether intentionally or not, lawyers might encourage their
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clients to exaggerate their pain in order to gain more compensation. Indeed with the
advent of contingency fee work for lawyers beginning now in Australia, the potential for
this sort of behaviour is even greater. Kennedy's (as cited by Mendelson, 1992)
comments where compensation neurosis is 'stimulated' by lawyers, are probably partially
responsible for this perspective.

Under 'no fault' systems, unless the claim is disputed there is often little need for a
lawyer. Indeed, many of the participants who had involvement with lawyers in their
litigation expressed considerable disappointment towards both the legal system and the
lawyer who represented them. This makes conspiracy theories about collusion between
the lawyer and participant to defraud the insurance company or defendant much less
likely than was originally thought might happen. To conclude, despite following
Mendelson's (1987) criteria for litigants this definition of litigation was probably too
loose, given the objectives of study, and therefore the result of having no effect on either
levels of pain or scores on the MDS is not surprising. Similar research in a country such
as America where the society is more litigious, and therefore there are more common law
claims, may find an effect using the same experimental paradigm.

The definition of litigation included any personal injury litigation in which a physical
injury was sustained and duly compensated. J! did not have to be directly related to the
back injury. At the same time it had to be a personal experience in litigation for an injury
in the past so a participant could have been a lawyer who specialised in personal injury or
an insurance assessor, however if they had no prior experience as a plan tiff in a personal
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injury claim, they would not be considered a litigant. Hence it was not legal knowledge
but personal experience that decided whether a participant was designated a litigant or
not. This was another area where perhaps the members of the police service, have a
stronger than average knowledge of the legal service. As was indicated regarding legal
personnel the police were not automatically used as litigants, unless they had a prior
personal injury claim that involved a common law claim or compensation for the injuries
sustained. Finally, as the results indicate, this did not appear to make any difference to
the results.

Procedural Issues
The procedural issues can be broadly defined as issues in the methodology which were
not planned for, and could be applied to most experimental research. The first issue
involved changing procedures during the experiment, which was unfortunate but
unavoidable due to the lack of adequate numbers of participants within the former pain
clinic client group. The change in populations has already been discussed, however the
change in format has not been. Essentially the instructions were changed from a letter
format to a simple instruction sheet; the actual wording of the scenario or instruction was
not altered in any way. While the instructions to participants were not altered at all, the
time given to consider possible presentation strategies was substantially reduced; from a
week down to only several minutes. The behaviour did not appear to change, indeed the
pain patients often read the instructions for a second time in front of the interviewer, as if
to remind themselves of their particular orientation. This did not suggest that they were
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very well prepared for the assessment, at least no better prepared than those who were
given the same instructions and several minutes to think about them. Unfortunately, as it
is malingering detection scale that is being validated it is not appropriate to use this
measure to determine whether a difference was made by the large increase in preparation
time that the chronic pain patient population had. Certainly, when asked if they
understood the instructions there did not appear to be any difference between the
participants drawn from different populations.

The former point, to an extent, leads to the· second. In the case of the chronic pain patient
population, as it was clearly some time since they had read the instructions, virtually all
the participants took the instructions with them to the assessment. This was regardless of
whether the assessment occurred at their home or place of employment. Similarly,
having opened the envelope the participants from the other populations would often place
the instructions to one side and rarely removed them from the table. As the experimenter
wrote the instructions, by even only briefly viewing the document, it was possible to
discern which set of instructions the participant had been given. In addition, participants
would often ask questions about the instructions, and while every attempt was made to
avoid being told the 'orientation' of the instructions of a particular participant, it is clearly
difficult not to take this into account. This naturally altered the blind nature of the
interviewer and therefore reduced the validity of the results; indeed it could be used to
explain the results completely. No record was kept of the number of times that the
experimenter was in no doubt of the orientation of the participant, however is was
probably close to one third of the participants.
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The issue is not so much whether the participant made the experimenter aware of his
orientation (malinger/non-malinger) but rather whether this made a difference to the way
the items were endorsed by the experimenter. In the community and police sample, the
participants were often assessed one after another with 6 participants tested on one day
and 4 on several days. This fact alone meant that instructions/directions, by the nature of
the research, were constantly changing. This made it extremely difficult to attempt to
remember whether a particular participant was malingering or not. Even within the
community sample close to one third were·malingering during their interview, making the
assessment almost automatic, with little regard for the orientation. Indeed the
experimenter would often give the participant the envelope with instructions, answer as
few questions about the instructions as possible, and then begin the interview without
looking at the discarded instructions. Future research should specify clearly ways to keep
the instructions from the interviewer as much as possible.

Finally, a substantial methodological issue was the low number of participants. The
original intention was to have 60 participants, so a two way ANOVA that did not violate
the homogeneity rule could be completed. This would have very clearly shown any
relationship between malingering and litigation for both reported pain and scores on the
MDS. Instead !-tests have been used, and the ANOVA's have been purely exploratory.
Subsequent research into validating this, or any other tool, should use more participants,
for no other reason than it would improve external validity.
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Implications of this Research
This research, due to the relatively low number of participants, will probably only have a
limited impact on malingering research, however the design considerations and issues
arising from this study should be heeded by future research. A range of issues have
arisen such as ethics in malingering research, subjectivity of pain and injury, the
similarities between other psychological disorders and malingering, the possibility that
successful malingering is not being detected by any of the scale currently used, and
finally the most appropriate methods of utilising this scale in the court, given the results
of the validation process. These issues are discussed in the light of the results of this
study, and the commentary from other researchers who have studied the different aspects
of this study.

Ethical issues in malingering research
Several authors have commented on the ethical considerations regarding research into
malingering, especially when it directly reduces the capacity of professionals to
accurately identify individuals who are malingering. Berry et al. (1994), Rogers (1997)
and Ben- Porath (1994) have all expressed concerns with indiscriminate publishing of
information directly related to a specific tool to assess malingering; or information about
an assessment that allows individuals to perform better or worse than they otherwise
would. Ben-Porath ( 1994) describes how the MMPl has lost much of its validity,
especially in regard to the dissimulation scales, due to the widespread publication of
results of studies. He states that a tension exists between needing to know problems with
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tests and providing more information to 'coaching staff' for more efficient strategies to
'beat' tests. Given the focus on litigation and lawyers it must be recognised that lawyers
are increasingly becoming psychologically aware; in part due to the journals designed for
both professions and bodies such as the American Academy of Forensic Psychology and
the Australian and New Zealand Association of Psychologists, Psychiatrists and Lawyers
(ANZAPPL).

All of the above authors indicate that experiments involving the coaching of people asked
to malinger are of the most concern. Rega'rdless, Berry et al. (1994) has suggested that if
it is accepted that the knowledge of how to successfully 'beat' tests will help malingerers
then researchers in this area have three options. The first is to suggest that they have no
ethical responsibility for this and research that will improve the tests should be placed in
journals as much as possible for peer review. The second option is that the researcher
assumes total responsibility, publishes few details and indicates in any publication that if
explicit results are required then he/she can be contacted. This is clearly time consuming
and will make follow up research more difficult. Finally, the researcher can choose to
publish the results only in journals that he/she knows will be read primarily by other
mental health professionals, rather than those from other disciplines. This, they
suggested, could be only A.PA publications. As Berry et al. (1994) commented it would
clearly be very difficult to assume that other professions are incapable of reading
professional journals for mental health professionals. The perspective taken in this
research is that explicit information will not be given in the body of this work but the
author is open to sending more details to other mental health professionals.
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Subjectivity of pain and injury
The hypothesis stating that the scale could classify to a significant level, those asked to
malinger from those asked to be honest, was supported by the results. When one looks
closer at the results of this study, without doubt, there is a much higher level of correct
classification of participants who were not malingering (94%) rather than those who were
malingering (44%). Further examination showed that participants not malingering had
significantly lower levels of reported pain than those asked to malinger.

The method used by many individuals who were asked to malinger, when asked after the
assessment, was as Lees-Haley's (1986) suggested, to remember prior extreme
experience with pain. This was done to focus their comments on the description of the
pain. For most of the participants the most extreme situation was nerve root pain, in
which a nerve is trapped between two intevertebral discs. They described lying on the
ground unable to move, and in total agony. The sensation left when the nerve was
released.

This memory of extreme pain and incapacity may have then impacted on other MDS
items that separated those asked to malinger and those asked to be honest. MDS items
which involved: description of pain, severity of injury, estimates of percentage function
lost and the potential to learn new behaviours may have been affected by this experience.
This is where sampling might have had an effect. A large percentage (62.5%) of those
who were not asked to malinger were drawn from the community sample. As previously

Validation of the MDS

118

indicated, the method of deciding whether a person was a possible participant in the
community sample was to ask them whether they had a 'bad back' or had injured their
back at some time and the resulting pain had lasted for longer than 3 months. There was
no other objective opinion given on whether a person had previously received an injury.
This is in contrast to the former pain clinic clients where 4 out of the 5 participants from
this population were asked to malinger. As was indicated most of this group had
undergone significant surgery for their pain and some commented that they found it
difficult to exaggerate their condition as it was already so extreme. Given this distinct
difference in the experience of pain and the lack of experimental control for the level of
injury, the reported percentages of behaviour that can no longer be completed were
naturally very high for those with prior/current experience of severe injury rather than a
direct attempt to malinger. This is not to say that some of the community sample had not
experienced significant injury, and been told that surgery should be considered, however
the pattern was not as common.

In this sense, what is being suggested is that a 'pain overlay' may be responsible for some
of the results where participants' different experiences of pain (based on the population
they were from) influenced their attempts at malingering in addition to a distinct attempt
to deceive. It should be recognised that when a bivariate correlation was completed on
malingering and reported pain scores there was not a significant relationship. This result
indicates that the instruction to malinger, rather than the general response to the MDS is
more predictive of increased pain. In this sense, the conclusion that must be reached is
that while the population that the participants are derived from is an important factor, the
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fact remains that all the participants had suffered from chronic low back pain at some
time making all of their experience important.

In other studies looking at methods of measuring malingering in chronic low back pain
populations this issue has emerged. In Chapman and Erena's (1995) study all those
participants with chronic low back pain labelled as inconsistent were inpatients rather
than in the community. Given this, theoretically these participants may be more injured
than those receiving treatment in the community. Contrary to this suggestion Leavitt
( 1991) found that those participants who were labelled as malingerers by his low back
pain simulation scale, on examination, had less tissue pathology yet reported more pain
than other participants. This appears to vindicate the inclusion in the current study of
chronic back pain sufferers with severe pathology or those who have undergone surgery
as neither has a strong impact on specific items used to assess malingering.

Future research will need to control for the severity of prior injury and utilise patients
already diagnosed by other professionals for internal validity, similar to Chapman and
Brena's (1995) research, to ensure that this participants are not malingering already. This,
in turn, would probably limit the use of severely injured chronic low back pain patients,
for to have surgery means that an objective measure must have identified a physical
deficit, which automatically would negate a label of malingering (Barkemeyer et al.,
1989). A design that would eliminate this problem would have two pain groups, one
suffering more pain than the other to see whether the group with more severe pain
differed on the MDS from the less severe, and to see how it would compare with a group
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asked to malinger. In the absence of such a group, it could be hypothesized given the
current results from hypothesis 4, that a more severe pain group would not necessarily
have higher MDS scores, in terms of just pain. The MDS places a strong focus on the
level of disability directly as a result of injury and it is on this basis that those with
significant injury (not necessarily reflected in pain intensity) would score higher on the
MDS than the less injured. The problem here is clearly one of definition, because if pain
is not used, but rather tissue damage, the argument becomes abstract, as definite long
term tissue damage would probably not attract a label of malingering by definition.

Overlap o( indicators of malingering with .1ymptoms ofAbnormal Illness Behaviour,
Functional Overlay and Factious Disorder with Physical Symptoms
To take the concept of subjectivity and pain further the Iink between abnormal illness
behaviour, which certainly includes chronic pain, and malingering will be examined.
This is not a new link. Clayer et at. (1984; Clayer et al., 1986) have examined this
concept. Abnormal illness behaviour is a defined as
an inappropriate or maladaptive mode of experiencing, perceiving, evaluating
or responding to one's own state of health which persists despite the fact that
a doctor (or other appropriate social agent) has offered an accurate and
reasonably lucid explanation of the nature of person's health status and the
appropriate course of management (if any) with the provision of adequate
opportunity for discussion, clarification and negotiation based on a thorough
examination of all parameters of functioning: psychological, social and
biological, and taking into account the individual's age, sex, education and
socio-cultural background (Pilowsky, 1994, p. 567).
Essentially the only difference between malingering and abnormal illness behaviour that
immediately comes to mind is the fact that malingering is very adaptive rather than
maladaptive; hence the term compensation neurosis or functional overlay is then used.
Clearly malingering is caught between these two definitions, and there seems to be no
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way to separate adaptive from maladaptive except when a specific statement of intent to
take advantage of a situation is made.

It is important to recognise that the definitions of functional overlay differ somewhat in

the Australian legal and psychological arena. In Federal Broom Co v Semlitch (1960)
119CLR626 the term was used to explain why after a woman had been treated for her
back injury, she then claimed that the injury had aggravated her schizophrenia, and that
her employer was responsible for this as well. The reason given was that despite the
schizophrenia being an existing condition under the legislation the employer was also
responsible when a physical injury lead to a mental injury. In this sense the dormant
schizophrenia was functionally activated directly as a result of the workplace injury. This
then 'overlayed' the physical injury and after the physical condition was clear, the
schizophrenic condition remained. This case is commonly cited in Australian law as an
example of functional overlay.

Main and Spanswick (1995) suggested that "the term function overlay as frequently
found in medicolegal reports is unhelpful and frankly at times misleading" (p. 750).
They indicate that it is used generally to indicate a 'non-organic' aspect of the his/her
presentation of the client's signs and symptoms. Frequently it is made in the absence of
physical findings considered adequate to explain the level of dysfunction or continuing
capacity of the client. Overall, Main and Spanswick (1995) suggest that this term should
no longer be used, and as Giles et al. (1997) suggest that with the advances in imaging
equipment, what is considered non-organic now may be considered a clear disorder in the
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future. In this sense, the overlay should be caused by the physical injury whereas the
legal definition appears to accept a pre-existing condition. This may be due to the older
reference to neurotic pain, that Clayer et al. (1984) suggested. This is now clearly
understood to be chronic, which is quite a different entity.

Main and Spanswick (1995) also advocate not using the term illness behaviour when
examining low back pain for similar reasons. They suggest that any behavioural signs
(guarded movements) or non-organic tests for illness behaviour (Waddell, McCulloch,
Kummel & Venner as cited in Main & Spanswick, 1995) are only testing the difference
between a distressed and non-distressed patient.

Pilowsky (1994) expressed the opinion that attempts to utilise items from the assessment
tool for abnormal illness behaviour (Clayer et al., 1984, 1986) in the detection of
malingering were "entirely misguided". While Pilowsky (1994) has this opinion, it is
interesting that Clayer et al. (1984) found that certain scales from the Illness Behaviour
Questionnaire could differentiate healthy participants asked to malinger from those asked
to be honest. Such individuals were termed conscious exaggerators. However when
suggesting the most appropriate method of diagnosing abnormal illness behaviour, it
seems to involve a disagreement with the doctor over an "inaccurate view of his health
status" (p. 570). Interestingly, it was a very similar item on the MDS (Item 13) that
separated those asked to malinger from those asked to be as honest as possible. This does
suggest that, at least in part, the difference between a diagnosis of malingering and one of
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abnormal illness behaviour is entirely dependant on the value judgement of the
assessor/health practitioner.

As Pilowsky (1994) himself notes
from the doctor's point of view, the challenge resides in having to convince
society that a person who refuses to cooperate with an 'appointed agent of
society' is entitled to the sick role, because the refusal itself represents
psychopathology and is the symptom of 'legitimate' illness. Society's stake
in this concept cannot be overestimated ..... For health services (and for the
legal profession which is so often involved) the concept of an illness
characterised by a mistaken belief in the presence of illness is difficult to
assimilate. It goes without saying that lurking in the wings is always the
spectre of the malingerer (p. 567).
Overall, this suggests, that as concepts such as adaptive and maladaptive are essentially
context based there appears to little to separate abnormal illness behaviour and
malingering.

Given the difference in the sample group used in this study (all chronic pain patients) and
Clayer et al.'s sample (1984) (healthy conscious exaggerators, chronic pain patients and
healthy controls) it is interesting to note what differences occurred. The items that Clayer
et al. ( 1984) found differentiated between those asked to malinger and either chronic pain
patients or controls involved: a greater emphasis on a change of emotions (relaxing,
depression), feelings that others are not accurate in their diagnosis of your condition and
the effect of the illness on family life. In this sense, Clayer et al.'s (1984) approach is
flawed as those asked to malingerer are clearly 'guessing' about the possible internal
emotions and effects on family life. In contrast, the individuals in the sample used here
know about the effects of chronic pain, and exaggerate the severity of the injury and the
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impact rather than the internal dialogue about being in more pain than others realise.
Indeed the difference between the scores of those with chronic pain and healthy
conscious exaggerators is large. This is because the conscious exaggerators do not know
what they are exaggerating. As was discussed previously, from a real world perspective
some injury is likely to occur during an accident, and exaggeration can occur however
this 'knowledge' of the condition is not taken into account in Clayer et al.'s (1984)
research.

Voiss ( 1995) supports some of Pilowsky's ( 1994) comments when he suggests that the
determination of fraud in a particular clinical case is primarily the responsibility of the
attending physician. However, he notes from his experience with 900 evaluations
assessing the validity of occupational injury, that the attending physician has often relied
on the subjective complaints of the patient and minimal if any objective data is used as
the basis for conclusions. While this has probably become more strictly controlled
recently, Giles et al. (1997) questioned even the validity of objective results for the
assessment of back pain . Ultimately, Yo iss (1995) suggests that collateral data should be
obtained more often and this data integrated into the available information in order to
make an accurate comment on malingering.

Yet another disorder that the symptoms of malingering are remarkably consistent with is
factious disorder with physical symptoms. In his overview Overholser (1990) suggests
that factious disorder can be discriminated from malingering through a number of
measures, the primary issue being that factious disorder occurs when a person simulates
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or creates somatic problems in the absence of clearly identifiable rewards. Gorman (as
cited in Overholser, 1990) suggested that as motivation is what differentiated the two
labels, one could look to psychological functioning rather than environmental factors as
an indication of rewards. An interesting point that Overholser makes is that "once it has
been determined that the patient's physical symptoms have been falsified, the
conceptualisation of the patient's problems often leaves the medical arena and enters the
realm of psychiatry or law" (p. 56). As was stated in the introduction Overholser (1990)
suggests that differential diagnosis is possible on based on the course of the disorder over
time, response to treatment and possible etiological factors.

When the differences between the two groups are examined again there is a reliance on
the two premises that motivation can be adequately assessed and that the malingerer is
not aware of the intricacies of a disorder. Lees-Haley (1986) clearly disagrees with the
latter assumption in the area of pain. In addition, from any of the reported research or the
MDS results it appears that given the item breakdown, it is not possible to adequately
assess motivation to deliberately exaggerate pain for the specific purpose of gaining
external rewards. The MDS, while attempting to assess goal and motives for the
exaggerated pain in part 2, was not subtle enough to gauge the goals of participants,
despite this goal being given to participants asked to malinger. This may have been a
facet of the instructions to participants, as they were asked to be subtle in their responses.
Overall, the likelihood of a person admitting that the pain will gain them money, and that
they would maintain this state by having the pain, is not likely to be high.
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Successful Malingering
The question that must be asked with any form of validation, is whether the instrument is
measuring what it claims to. The nagging doubt that Rogers and Cruise's (1998) study
generated for this, and indeed all malingering validation studies, is whether malingering,
if successful, is actually detected. Surely successful malingering requires that it is not
detected, meaning that the given diagnosis stands and therefore the malingerer goes
unnoticed. In this situation, the instructions given to those asked to simulate malingering
would be blamed for not explaining the direction to malinger in clear enough terms.
Alternatively the participants may simply not have the ability to simulate malingering.
Even in a known groups design, perhaps the patient who does not attract attention by
being uncooperative, complaining of absolutely no lowering of pain through treatment
and not expressing a strong desire to gain compensation is simply a more effective
malingerer rather than a 'genuine' chronic pain patient. Despite these concerns the
results of this study do appear to indicate that the participants did exaggerate their pain on
the basis of the instructions given and the MDS did appear to detect this difference in
response.

Presenting evidence of malingering in Court given these results
It is clear that matters of fact must still be decided by the court and while taking into

account the opinion of experts, it is the court's role to decide. So Mendelson and

Validation of the MDS

127

Mendelson (1993) suggest
the task of the forensic psychiatric expert witness should be confined to
issues of diagnosis of mental disorders, their aetiology, and the degree of
psychiatric impairment. The psychiatrist may draw attention to
inconsistencies in the histories obtained and on mental status examination,
poor treatment compliance, and the lack of cooperation or motivation during
the course of the treatment or rehabilitation program. However the specific
question of the veracity of the claimant is for the court to decide (p. 34).
It is for this reason that Mendelson (1992) states that "the judicial system is paying

increasing attention to the recent advances in the understanding of mechanisms which
determine the experience of pain" (p. 122). Main and Spanswick (1995) note that it is
'customary' that the court will turn to the opinion of a pain specialist (psychologist,
anaesthetist) in back injury only when orthopaedic evidence is irreconcilable or is unable
to explain the persistence of pain or dysfunction.

In regard to presenting evidence of malingering to the court, several authors have made
comments regarding the format and the credibility that should be given to an expert
witness. Ogloff (1990) has identified 3 areas used to determine whether evidence is
deemed admissible or not. First, it must be decided whether or not the evidence is
relevant or not, and as was just indicated in cases where the identified tissue injury is
approximately equal to the level of reported pain then it does appear that psychologist's
discussion of malingering is probably not rele~ant. As Ogloff (1990) indicates, only
when the issue of pain or the defendant's mental state becomes an issue will a
psychologist be deemed eligible to enter the field, and within this context he/she can only
safely comment on the veracity of a defendant's mental condition, not on the issue of
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veracity in general. In Commonwealth v. Zamarripa (1988) 379 Pa.Super, 10 A.2d 980 it
was held that
the veracity of a particular witness is a question which must be answered in
reliance on the ordinary experiences of life, common knowledge of the
natural tendencies of human nature and observations of the character and
demeanour of witness. As the phenomenon of lying is within the normal
capacity of jurors to assess the question of a witness's credibility is reserved
exclusively for jury.

Second, the process of labelling someone a malingerer, by a professional, is problematic
within the legal system. Most legal jurisdictions accept that the probative weight of an
expert's testimony value should not be outweighed by the risk of unfair prejudice. This is
probably difficult to avoid, as the term malingerer, is strongly biased and as was
previously stated, it is not a diagnosis but a legal and military label. As Ogloff notes
"courts are especially reluctant to admit expert evidence, for fear of its prejudicial impact
when the foundation of the testimony is at all equivocal" (1990, p. 38) and labelling an
individual as a malingerer certainly has that element. At the same time however the term
'malingering' appears in legislation, so it must be defined and used within the court
system at some point.

A possihlc means of countering this effect has been suggested by Mossman and Hart
(1996) in which rather than a clinical decision of either malingering or not malingering, a
comment on the likelihood of malingering is made instead. This, it is suggested would
increase the predictive ability of clinicians, as a probability formulae would be utilised,
rather than a simple decision made. It is proposed that a distribution be developed by the
clinician using Bayes Theorem, from which estimates can then be compared within a
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known groups design. This approach is actuarial in design, but the concern still remains
about what to do with this information and Mossman and Hart (1996) provide little
indication. For example does this result mean that if there is a 60% possibility that the
plantiff is malingering his/her back pain, then similar to contributory negligence, should
be lower the amount of compensation accordingly? Alternatively, should the fact that
there is 60% possibility of malingering mean that this is more than the balance of
probabilities (50%) and therefore in a civil case, the plantiff should lose the case?
Clearly the answer does not necessarily lie with psychology but the way the courts
choose to usc the information.

One of the foundation premises that Mossman and Hart (1996) use is that "many
malingering measures are highly accurate" (p. 286). The evidence presented in much of
the research suggests that this is due to the types of validation procedure since no one test
has been shown to be 'highly accurate' (Rogers, 1997). Ultimately, Mossman and Hart
(1996) acknowledge that the tests used to assess their theory, assess misrepresentation
rather than malingering. Given the previous discussion on conscious and unconscious
motivation it appears that an assessment for malingering should assess the motivation for
attempting to appear impaired before giving a conclusive label. Indeed, Rogers, Sewell
and Goldstein (1994) have suggested that there are different types of reasons behind the
motivations to malinger: pathological, criminological and adaptional. Their research
indicates that medicolegal evaluations are generally adaptional which makes it applicable
with the techniques employed by the MDS to assess malingering. Specifically, part 2 of
the MDS does seek to assess the motivation, albeit very simplistically, and given the
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range (0-29) of scores it is possible to generate, Mossman and Hart's (1996) probability
approach might work with this scale. This presumably would replace the cut off point of
7.6, which might be more amenable for the court.

The final point is that the evidence given must satisfy the Daubert rules (Daubert v
Merrell Dow Pharmaceuticals, 1993) in which the expert must have some special
knowledge not generally available, the assessment procedures used must be based on
research commonly accepted by the majority of the scientific community and above all
they must be falsifiable. This is part of the problem because, through the use of known
group designs where another professional has given some participants the label of
malingerer this research indicates that it is not falsifiable, as it based on opinion.
Similarly simulation designs may not sufficiently motivate participants to attempt to
exaggerate their condition, to the same level as 'real' malingerers. Overall the reason for
this problem is that evidence of a specific intent to deceive solely for the purpose of
external gain is required for the label of malingering to be applied and currently, no study
has assessed for this. Instead, many theorists have extrapolated from the context of the
injured party, generally litigation, and assumed that the person is malingering for this
reason. The result is that a number of diagnoses can be applied, such compensation
neurosis or abnormal illness behaviour, which suggests that malingering as a concept has
not been shown to be falsifiable.

The case of Frye v United States ( 1923) 293 F.l013 from which the rules regarding the
admissibility of scientific evidence were developed prior to the Daubert decision, is of
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interest as it concerned the ability of science to detect deception through an early lie
detector. In Frye v United States it was noted that
just when a scientific principle or discovery crosses the line between
experimental and demonstrable stages is difficult to define ... somewhere in
this twilight zone the evidential force of the principle must be recognized
.... the thing from which the deduction was made must be sufficiently
established to have gained acceptance in the particular field in which it
belongs.
Research into malingering, while having generated considerable levels of research, has
largely failed to show that clinicians have effective means by which to assess deception
(Ogloff, 1990). Indeed Oglotf (1990) concluded by saying
trouble may be brewing for clinicians and attorneys who attempt to admit
testimony about malingering and deception ... although expert testimony
regarding the admissibility of malingering and deception has not been
challenged too frequently in the past, attorneys who become aware of the
inherent limitations of clinicians to accurately identify malingerers may begin
to challenge expert testimony more often (p. 41).
Overall, Ogloff ( 1990) indicated that the rules of evidence are still probably broad
enough to allow the admissibility of expert testimony regarding malingering, if the expert
has first hand knowledge of the suspect or plan tiff, but not as a concept in general. What
is important therefore, is that an expert must not misrepresent his/her skills to the court,
and given the current state of research into malingering and deception this criterion does
appear difficult to fulfil.

Future Research
The results of this study and the comments by some participants, in the light of the
literature, suggests that there is some scope for future research into the malingering of
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pain conditions. The areas of future research cover both conceptual and procedural issues.
While there are many potential areas, the specific areas identified are: the relationship
between age and motivation, the use of money as an incentive, asking a participant to
differentiate between their responses when asked to malinger and when giving a true
response, and finally, what the best method is of assessing whether a client presenting
with chronic low back pain is exaggerating or not.

Age and motivation
Areas that were not directly related to the research questions such as the effect of age on
malingering and age on pain were assessed to look for possible covariates to the main
effects. Hall and Pritchard (1996) suggested that generally malingerers are in their late
20's and early 30's. The current study clearly does not represent this group with the
average age around 40 years old. When bivariate correlations were completed on age for
both MDS scores and reported pain levels neither showed a significant relationship. This
result was supported by Mendelson (1987) who also found no relationship between age
and the conscious exaggeration scale. As one participant, who admitted exaggerating an
earlier wrist injury, suggested when you are young you want to work again and just want
to have an extended rest. He then made the point that older people (specifically workers)
when they near retirement age, may exaggerate an injury to get out of the work force
earlier than they would if they retired. Several authors have suggested that the rate of
workers' compensation claims rises when a company announces it is downsizing for
similar reasons (Bowles, Duggan, Forbes & Tongs, 1997). This suggestion does have
some intuitive appeal and while it was not a significant correlation in the current study,
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this was probably due to the homogeneity of the sample age and the impact of the
instructions to malinger.

Future research should firstly assess whether an age effect does exist on MDS scores and
levels of reported pain with those relatively early in their career and those towards the
end of their career. Measures such as the MDS without the direction to malinger could
simply be given and the scores assessed as to whether a difference does exist on the basis
of age. If this were so, further interviewing could be completed to assess the different
goals that individuals have on the basis of age. Then the different strategies employed by
individuals of different ages when attempting to malinger to gain these goals could be
assessed.

Money as an incentive
When this research was proposed the possibility of positive incentives for malingering
was canvassed on the basis of Rogers's (1997) discussion of external validity. The issue
immediately arose of how could this be done? Should money be used as the reward for
(un)successful malingering in which a client does score highly on a malingering scale,
and if so how much? Certainly the $50 incentive Rogers and Cruise (1998) offered
students is a good reward for this population, but how does this compare to individuals
who are attempting settlements worth hundreds of thousands of dollars? The conclusion
was that very little could be offered in financial terms for incentive and as was previously
indicated the University ethics committee would not allow such action. Future research
may have to conduct interviews as part of any pilot research for simulation designs so
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accurate rewards can be defined on an individual participant basis. Overall, it does not
appear possible to use direct financial reward as a means of motivating participants
familiar with the system of compensation, as no researcher would have the financial
resources to make the positive incentive as great as it is in the litigation system.

Ask participant what a true response would have been to differentiate responses
Currently a control group is used to denote what would have been expected for a person
asked not to malinger. However, it seems appropriate to ask participants who were asked
to malinger what their responses would be. if asked to be as honest as possible. This
could be completed in a repeated measures design. This does not appear to have done in
malingering research yet which is problematic as it is still not entirely clear what aspects
of behaviour alter due to the instruction to malinger. Indeed, such research would allow
greater insight into the most effective method of asking individuals to malingerer when
validating instruments. Even with Rogers, Cruise and Sewell's (as cited in Rogers, 1997)
instructions, it is not conclusive whether instruments are measuring an attempt at
malingerer or some other behaviour. This differential is critical given the overlap that
this research is suggesting exists between abnormal illness behaviour and malingering.

What methods does this research suggest may make it possible to detect malingering in
individuals presenting with chronic low back pain
There are several points that can be made on the basis of this research and the arguments
made by some researchers, which allow psychologists, to some degree, to detect
malingering. The first point that is that the goal of the malingerer is to perform in the
assessment, but then quickly remove himself from treatment, as he/she wants the
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pecuniary benefits rather than the problem solved. Given this Ogloff (1990) suggests, as
a means of separating individuals with factitious disorder with physical symptoms and
those who are malingering, that the client who indicates a readiness to undergo surgery is
more likely to be presenting with a factitious disorder with physical symptoms than
malingering. Australian courts may not accept this however, according to Mendelson
( 1996), and he cites the case of Basili v Australian Telecommunications Corporation
(1991, Unreported Federal Court). In this case the plantiff developed low back pain at
work and subsequently had a spinal fusion. It was held that despite the plantiff
undergoing, what the AAT (para 20 Administrative Appeals Tribunal) noted was "the
most painful and, indeed dangerous, surgical procedure of spinal fusion" they held that
this had been "a deliberate and calculated attempt to obtain compensation for an injury
which has long since recovery" (para 19 of Federal Court decision).

A second point is that of the participants interviewed for this research often had complex
symptoms and aetiology's which unlike a malingerer, they were very keen to talk about.
The third point is that all the participants could precisely identify behaviours which cause
them pain, and would show some fear-avoidance behaviour when asked to show where
the pain occurs. The fourth point, is that contrary to the presentation of constantly high
levels of pain, all participants reported significant variation in the level of pain, and that
with some treatments short term relief was experienced. In this sense, an unsophisticated
malingerer would probably attempt to show that no relief has been gained. The results of
the MDS, even those asked to malinger, do not show this occurring.
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The importance of assessing motivation is crucial and measures must go beyond
establishing just a need (i.e. individual is not wealthy) but rather establish intent, just as
in criminal trials. There needs to be a greater focus within the definition of malingering
on the difference between external and internal goals and the use of pain as a tool for
manipulation. In the case of malingering, it is deemed to be fraud under workers'
compensation legislation, because the community is having to pay money to an individual
who does not deserve it, however in factitious disorder with physical symptoms a person
who uses his pain to avoid housework is seen as lazy. Conceptually I consider the same
intent is operating, just with different consequences. Part 2 of the MDS showed this in
the types of goals mentioned by participants, very few were directly related to money
which is what compensation neurosis assumes. In short, while the same techniques of
emphasising pain behaviour are occurring; it is the social context of where it is occurring
that dictates whether the label of malingerer is applied. There needs to be more
discussion on what the underlying factors of deception are, and what they attempt to
address rather than allowing the social context to dictate whether a person is malingering
or suffering from abnormal illness behaviour. Currently, the researchers are not tapping
into this area of motivation, and instead both labels, from the research appear to present
in the same way.

Conclusion
This research, rather than validating the MDS has given valuable insight into the
possibilities for future malingering research. Forensic psychology currently has
considerable research into this area, however there is an over reliance on so called
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'known groups' designs, by targetting those with litigation and the assumption that the
potential malingerer is operating from a completely ignorant standpoint regarding his/her
faked/exaggerated condition. This has made much of this research unusable for the
courts. Overall, the results do indicate that the instructions, which Rogers (1997)
suggested are often the weakness in a study, do appear to have had some effect on the
participants' performance. Certainly, these results are only applicable to men with
chronic low back pain with more research required before any comment can be made
about the MDS with either females or other pain/neurological disorders. The MDS,
appears to successfully differentiate between participants attempting to malinger from
those who are not; essentially on the basis of an over-estimation of pain and severity by
the participant. This subjective response clearly, overlaps with many of the concepts of
abnormal illness behaviour and it is only through researchers strictly controlling the level
of injury (and the population from which the participants are drawn) and focussing on
motivation that this will any method of differentiation can be reliably developed.

A difficulty with the measurement of pain and malingering is the reliance on self report
which would appear to lend itself to malingering. The subjectivity of pain sensation is
well documented (Dworkin & Whitney, 1992) making direct objective comparison
difficult and the point must be made, that pain does not necessarily involve tissue
damage. Perhaps as Giles et al. (1997) suggest, it is only through the progression of
imaging technology, that patients accused of malingering will be vindicated and those
attempting to malinger will be less confident. Finally, the greater the level of
understanding about the different qualities of individual pain syndromes, the more
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difficult they will be to malinger. However, attempting to assess malingering of pain as
an individual entity, in the absence of a specific diagnosis, is, on the basis of the current
research and at a level accepted so it would accepted by the court, virtually impossible.
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APPENDIX B
SCREENING TEST -JOHN HOPKINS CHRONIC PAIN CENTRE
DESIGNED SPECIFJCAU.Y FOR BACK PAIN (Dr Donlin I.oog)

l. When did you first notice the pain that you now experience?
a) Sudden onset after/with an accident or definable event.
b) Slow, progressive onset with sharp accompanying pain.
c) Slow progressive onset without sharp accompanying pain.
d) A sudden onset of pain without an accident or event to which you can tie the pain.
2. Where do you feel the pain?
a) One specific well defined place.
b) Several different places.
c) One place but hard to tell exactly where.
d) Its hard to describe exactly where the pain is and it feels differently in different places.
No physician has ever been able to tie it to a specific source.,
3. Do you have trouble sleeping at night?

a) If yes then go to question 4
b) If no then go to question 5
4. What keeps you from falling asleep at night?
a) I have trouble falling asleep at night because of the pain an<! I'm awakened by the pain
at night.
'
b) Because of the pain I have trouble falling asleep about three times a week or more and
I'm awakened by the pain from sleep more than three times a week.
c) I have trouble falling asleep more than three times a week but I'm not awakened from
sleep by the pain more than '!Wice a week.
d) I have no trouble fallins asleep because of the pain and it does not wake me once I am
· asleep.
e) I have trouble falling asteep or I'm awakened early in the morning -but its not because
of the pain.

5. Does the weather affect your pain?
Cold and Wet- Doesn~ affect
6. How would you describe the type of pain you have now?
Burning sharp - Excruciating, unbearable
7. How frequently do you have pain?
Constant - Occasionally present 25% of time

•

8. How does movement of position have an effect on the pain?
Unrelieved by position change or when don't use part of body that hurts. Numerous
operations for the pain. --- No change in pain with position change or not using hand but
there is no operations for pain.

9. What medications have you used in the past month?
No medication at all
Non narcotic pain reliever or a mild tranquillizcr (non~benzodiazcpam) or an
antidepressant.
Strong pain killer or a sleeping pill less than 3 times a week or I've taken bcnzodiazepam)
tranquillizer less than three times a week.
I've used either a pain killer or sleeping pill or tranquilli1.er more than four times a week.

10. What hobbies do you have? Can you still participate in them?
I am unable to participate at all in any hobbies I used to enjoy. --- I still participate the
same as before.
II. How frequently did you have sex and orgasms before the pain? How frequently do
you have sex and orgasms now?
Formerly good (3 to 4 times a week) Now less than once a week----I am unalble to have
any sexual contact since the pain and I had difficulty with orgasms or erection prior to the
pain.
12. Are you still working or doing your household chores?
I work every day at the same job prior to the pain at the same level with the same duties.-~1 don't work any more someone else does my household chores.
13. What is your income now compared to the time before your injury or beginning of
your pain? What are the sources of your income?
rm experiencing financial difficulty and my family income has been cut in half or more
since the onset of pain.
b) Family income 50- 75% prepain
c) I am unable to work and recieve some compensation and my spouse works. My income
is at least 75% or prepain.
d) My income is about eighty percent or more of my gross pay before the pain and my
spouse does not work.
14.Are you suing anyone or is someone suing you or do you have an attorney helping you
with compensation or disability payment?
a) I have no suits pending and do not have an attorney
b) I have a suit pending but it is not related to the pain
c) I am being sued as the resuit of an accident
d)! have a suit pending, or workers compensation and I have a lawyer involved.
15. If you had three wishes for the world for anything in the world what would you wish
for?
a)Get rid of the pain would be the only wish
b)Get rid of pain would be one of the three wishes.
c)Something of a personal nature such as more money

d) Something for others such as an end to world hunger.
16. Have you ever been depressed and thought of suicide?

a) Depressed or have been depressed in addition to having pain. My depression makes me
cry sometimes or think of suicide.
b) Because oft he pain I have been depressed and felt guitly and angry
c) I felt depressed before the pain as l suffered a financial or personal loss and now with
the pain here I also have some depression.
d) I don't feel depressed, l don't have crying jags or I don't feel blue.
e) Before the pain l had a history of suicide attempts.

17 points- Coper: 94% you have a physical problem that would be identified by at least
one objective test.
18-20 points Exaggerator/Coper: 75% you have an organic problem that will show up
with testing but you may also have had some problems prior to the pain
21-31 points Exaggerator: Surgery recommended with caution. Test shows you may have

found a use for chronic pain. Treatment emphasis on attitude change toward chronic pain.
32+ points Psychiatric consultation needed. Surgery should not be carried out without
psychiatric evalUation as you freely admit that prior to the pain you had many problems.
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APPENDIX D

Summary of Malingering Techniques
l.

The malingerer may express an exaggerated degree of confidence in the physician· s ability
to diagnose his alleged neurological disorder.

2.

The malingerer may make self enhancing statements .

3.

The malingerer may make denigrating statements about the competence of other
physici'ans and/or denigrating statements about the character of other patients.

4.

The malingerer may emphasize the severity of his alleged neurological symptoms.

5.

The malingerer may emphasize the severity of his alleged neurological impairment.

6.

The malingerer may emphasize a specific etiology of his alleged neurological disorder
without the consideration Of alternative etiologies.

7.

The malingerer may emphasize a temporally associated event, not known to have a cause
and effect relationship with his alleged neurological disorder, as the etiology of his alleged
disorder.

8.

The malingerer's symptoms may not be improved by symptomatic treatment.

9.

The malingerer may allege that his neurological disorder is responsible for what was clearly
a voluntary act.

I0.

The malingerer may present a constellation of symptoms not consistent with those of an
established neurological disorder.

II.

The malingerer may emphasize his alleged inability to perfonn his job related activities ..

12.

The maiingerer may deny the ability io learn new skills to compensate for those allegedly
lost from his alleged neurological disorder.

13.

The malingerer may emphasize the certainty of another physician's diagnosis of his alleged
neurological disorder.

14.

The malingerer may emphasize the prestigious status of another physician who allegedly
diagnosed his alleged neurological disorder.

15..

The malingerer may quote an alleged authority mi the subject of his alleged neurological
disorder.

16~

The malingerer may use an irrational analogy to stress the seriousness of his alleged
neurological disorder.
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Pain Intensity Scale
Please rate your pain by circling the most appropriate number
at 4pm, every day for one week.
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Worst Pain Imaginable

No Pain

Day One

APPENDIX F

Instructions

For the purposes of research, you have been asked to participate in a 20 minute painevaluation interview. Please pretend that the interviewer is an insuran('e appointed health
practitioner with the purpose of dctCnnining what compensation you will receive for your
chronic low back pain. The more realistic you can make this interview the value of the
research increases. You do not have to plan what you are going to do, but rather do what
you would think would best meet your goals.

During the interview, try to convince the assessor that your pain is very bad, worse than it
actually is, in order to gain more compensation. Use all your experiences, if you have
involved in workers' compensation or litigation use these experiences to increase the
amount of your claim. Use any experiences that you have had in your life, or advice you
have received from other people. Subtlety is important. Remember that the pain rating
scale sheets with 1 - 50 are part of the evaluation so also use these to show how much
pain you want the assessor to think that you have. Overall. keep in mind that the more
pain that the health practitioner believes that you have, the higher your claim will be.

If you have any questions at the end of the interview the assessor would be more than
happy to answer them and to explain fully the goals of the research.

APPENDIX G

Instructions
For the purposes of research, you have been asked to participate in a 20 minute pain
evaluation interview. Please pretend that the interviewer is an insurance appointed health
practitioner with tht! purpose of determining what compensation you will receive for your
chronic low back pain. The more realistic you can make this interview the value of the
research increases. You do not have to plan what you are going to do, but rather do what
you would think would best meet your goals.

During the interview, try to be as honest as possible about your pain. When you fill out
the five 1 -50 pain rating scales prior to the interview, try to be as accurate as possible.
Overall, you feel confident that you will gain the compensation that you are entitled to.

If you have any questions at the end of the interview the assessor would be more than

happy to answ~r them and to explain fully the goals of the research.

APPENDIX H

MALINGERING DETECTION SCALE INTERVIEW
SCHEDULE
PART ONE
Introductory Phase
Greetings
Preferred Name:
Code Number:
Date ofBinh _ _ _ _ _ _ _ _ _ _ _ __

How long have you been in pain?,_ _ _ _ _ _ __
1.
2.
3.

How do you feel about me assessing you for your pain?
Do you think that it will make a difference for you (Exaggerated Confidence)
What is your position in society? (Increase his social status) (Denigrate others)

Must be Spontaneous Comments by Patient
History Taking Phase
Focus is on the Severity of the Pain
1.

2.

Tell me about the pain (Evasive?) Can you describe the pain (Describes using
severity instead of actual description)
What has the pain affected in your 1ife, what have :·<:hievements have you had in spite
of your pain (Exaggerates degree of impairment, G.;nuine patient can and will

describe achievement)
3.
4.
5.

6.

Tell me about how and when the pain began ([s this a cause and effect relationship
that has some validity or does this give no rationale for the pain)
Are there ~y other explanations for why the pain exists (Consider alternatives when
not obvious,.can y.ou describe wba\ occurred before the pain began) ..
Have you attended treatment previously and how did you respond (Beneficial
response does not help the malinger, no improvement at all)
Did you have any unusual responses to treatment (Again is this rational, or does this
indicate perhaps a reason to avoid treatment)

•

(In general are they denying responsibility for clearly voluntary acts despite
behaviour clearly being motivated, provoked, directed or complex)

7.

What other symptoms do you have because of your condition (Are these symptoms
reasonably connected to the pathology, and can they be explained in a rational
manner)

Leading Questions: a) Do you feel pins and needles in your hands
b) Do you get a aching feeling in the soles of your feet
c) Do you get a burning sensation in your eyes

9. Can you give a percentage ofnonnal behaviour that you can no longer do solely
because of your pain.
(Look for extreme results "can't do anything")
10. Have you attempted to learn new skills to compensate for those abilities lost due to
pain (Malingerer has not attempted to learn new skills)
11. Do you think that you will be able to learn new skills
12. If not, why not. Have you received training in other areas (He will stress that he has
not been trained in other areas)
History Taking Phase
Manipulation Attempts

1. Have you been to other health practitioners- Were they good?
2. (Emphasises the prestige of another examiner who has allegedly found a pathological
condition and/or quoting an authority on the subject.)
(Any attempt to create self doubt in the examiner. Should question whether history
and examination are consistent with these alleged authoritative quotations.)
3. What were their findings (Were their findings positive then say that they were the
best or denigrate them if findings were inconsistent with patients views)
4. (In general did the patient irrationally suggest other situations or examples where an
examiner ignored similar symptoms and the patient suffered or died. This forces the
examiner to disprove an irrational analogy thereby gives the malingerer control and
demonstrating a lack of knowledge and reasoning ability)
4. What will you do if relief cannot be given (Threatening selfhann or banning others,
and maling~er is responsible for the threat not the examiner)

5. What do you think that I can do (Overstating the examiner's authority for intervening
on the patient's behalf, common technique- based on inadequate information by the
malingerer. Gennine pain patient concerned with truthful authoritative position as
this allows him to anticipate the benefits of working with this examiner. Or the truly
ill may lack concern for the examiner's authority believing that illness or impairment
is an adequate reason for appropriate support regardless of the examiner's authority.
No benefit is made to the truly ill patient by falsely inflating his examiner's authority)
6. What will you do if! choose to say that you have less back pain that what you claim
(The malingerer may threaten the examiner with legJI retaliation for a missed
diagnosis or improper care which can cause self-doubt and fear of retaliation in the
examiner. This attempt at manipulation should increase examiner's degree of

uncertainty regarding the patient's diagnosis. The results alone should be able to
justify the examiner's decision.)

Remember: Patient's answers to questions
•
•

General: Patient questioned the competence of the examiner to avoid answering
questions
Patient gave an affirmative response to an inappropriate leading question: Sec before

Examination Phase

1.

What actually causes you pain. Can you suggest some activities and show me why?
(Any physical effort resulted in enhancement ofthe patient's presentation of
symptoms)

2.

Patient's responses during the examination did not support a physiological
explanation. Explanation is given but is irrational and clearly manufactured.

Patient's response to disagreement
•

Patient's response to the examiner's explanation suggested a distorted meaning of the
examiner's statement. Continuously misunderstanding examiner's statement to avoid
acceptance of the examiner's explanation, despite the explanation provided on an
appropriate cognitive level for the individual.

•

Patient demanded an explanation based on inadequate data. They demand an
explanation of symptoms based on inadequate data, not possible to give as diagnosis
is unjustifiable

I.

Why do you think I am asking you these questions? (This is another mechanism to
avoid acceptance of the examiner's impression. If the examiner is discredited then his
impression becbmes invalid. The examiner should question the reason why the patient
would reject his impression especially if the examiner's impression carries a good
prognosis.
PART TWO
Apparent goals for patient's behaviour
1.

By having this pain what responsibilities or activities, that you do not enjoy, can you
uo longer perform.
2. What will you gain by having this pain? (A goal was identified for all the patients
classified as malingerers by the MDS i.e. money, disability status, narcotics)
3. What do you maintain by having this pain?

APPENDIX I

EDITH COWAN
UNIVERSITY
PERHl WESTERN AUSH1ALIA
JOONDAI.UP CAMPUS

II)(} Joondalup Drivr.. Jrmndalup
Western Ausrralia 6027

Telephone (08) 9400 5555
Facsirnllr. (08) 9300 1257

Dear _ _ _ _ _ _ _,
With regards to our phone conversation I wish to thank you for agreeing to be part of
this research by Edith Cowan University in association with Brain Suter and Dr. Phil
Finch. This research is part of a Master's thesis and should be useful in reducing

conflict between patients and the insurer.
For the purposes of research, you have been asked to participate in a 20 minute pain
evaluation interview. Please pretend that the interviewer is an insurance appointed
health practitioner with the purpose of determining what compensation you will
receive for your chronic low back pain. The more realistic you can make this
interview the value of the research increases. You do not have to plan what you are
going to do, but rather do what you would think would best meet your goals.

During the interview, try to be as honest as possible about your pain. When you fill
out the five 1 -50 pain rating scales prior to the interview, try to be as accurate as
possible. Overall, you feel confident that you will gain the compensation that you are
entitled to,

If you have IDly questions at the end of the interview the assessor would be more than
happy to answer them and to explain fully the goals of the research.
Please find enclosed:
a)

5 pain rating scales, to be completed daily, and started 5 days prior to the
interview. I will take these at the interview.

b) An informed consent form, Please read this and sign the tear off section, I will
take this at the interview.
c) A reminder slip for your fridge, with the interview time clearly stated.
d) A cover letter from Brian Suter and Dr. Phil Finch, explaining their role in, and
endorsement of, the research.

JOONDALUP CAMPUS
100 Joondalup Drtve, Joondalup
Wes1em Allsttalia 6027
Telephone (08) 9400 5555

MOUNT LAWLEY CAMPUS
2 Bradlord Street, Mount Lawley
Weslern Australia 6050
Telephone (08) 9370 6111

CHURCH LANDS CAMPUS
PearSon Slreet, Churchlands
Weslern Australta 6018
Telephone (08) 9273 8333

ClAREMONT CAMPUS
Goldsworthy Road, Claremont
Weslern Australia 6010
Telephone (08) 94421333

SUNBURY CAMPUS
Robertson Drive, Sunbury
Western Australia
Telephone (08) 9780 7777

APPENDIX .J
Telephone Contact with potential participants

I.
2.
3.
4.
5.
6.
7.
8.

Ask for individual by name (Mr
)
Greetings- Full Name
Masters Student in Psychology at Edith Cowan University
Conducting research in association with Brian Suter and Dr Finch.
Asked for a list of individuals who have suffered chronic low back pain
Have not seen personal files, only been phone numbers.
I am ringing to ask you to participate in this study
The study is designed to "reduce the conflict between health practioners conducting
assessments of pain for insurance conflicts..
9. Many of the claims made that a person is faking pain is made on the basis of the
practioners 'gut feeling', which is not acceptable.
10. It will involve filling out giving an indication Of how much pain you are feeling at a
particular time each day (from 0 to 50) and a 15 minute interview to be conducted at
your home, Brian Suter's office or Edith Cowan University at the best time for you.
11. Some of the patients will be asked to pretend that they are in pain while others will
not. People who are pretending wil1 be asked to try and convince the interviewer
using whatever means they wish. This will be an opportunity to use some of the
negative experiences you have had, especially in the Workers Compensation arena.
12. Your participation will not affect your current treatment whatsoever and no one else
will have access to this information. You can pull out of this research at any time,
even after you have agreed.
13. Are you interested?
14. No- thank you for time, if you become interested later my contact number is
94005418
15. Yes- Thankyou for agreeing to participate.
16. You will be sent a package in the mail containing an informed consent form, a letter
giving you instructions to either pretend to have more pain or give honest answers, 5
pain sheets which are to be filled out starting from the day that you receive the
package, a reminder sheet for your fridge for the time and day of the interview and a
letter from Brian Suter and Dr Finch explaining their role and support for this project.
l7. What is your address so I can send you the package?
18. We need to set a time for the 15 minute interview to take place. A time preferably
when their will not be too many distraction would be ideal. I have fairly flexible
times both during the day, at night or on the weekend. What time best suits you?
19. That time will be fine, is your postal address different from where you Jive? If so
where do you live?
20. Thankyou for your time, if you need to change the time please ring me on 94005418
or 92444012 as soon as possible so we can work out a mutually agreed time. I look
forward to seeing you on ----------- at-----------.

Bryan Suter
B.Soc.Sc.(Hons), M.A.(Ciin.Psych.)
Cl1mcal Psychologist

BS:vg\cunrd25.S05

APPENDIX K
25 May 1998

Dear
This is to introduce David Cunrow, a second year Masters student in the School of Psychology at
Edith Cowan University. I was approached by David and the university to conduct research on
the ways individuals express their pnin in and outside of a litigation situation. I agreed to
participate and provided him a list of names and telephone numbers of previous patients whom I
felt would be motivated to participate ir. tnis study and who met the requirements of the study.
No further records were accessed, nor was infonnation regarding your. presenting problems,
history or treatment shown to David Cunrow or his supervisor. At no stage will he nor anyone

associated with this research have access to this or other confidential treatment infonnation.
As you may know, I am a finn believer in ongoing research. I appreciate that this research
project involves a reasonable· time commitment. Nevertheless I would request your favourable
consideration of participation. Shoulrl you agree to participate, you are elcome to withdraw
your participation at any time.
Should you have any questions regarding this research, please do not hesitate to contact me on
the number below, or alternatively contact David or his supervisor, Dr Irene Froyland, on 94005414.
I hope this letter finds you well.
With best wishes
Yours sincerely

BRYAN SUTER
cc

Psych File

18 Hardy Street (PO Box 734) South Perth WA 6951. Tel (08) 9367 4466. Fa (
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APPENDIX L
Information and Consent Form

My name is David Curnow ami J would like to thank you for your decision to
participat~ in research, for my Masters thesis, in the School of Psychology at Edith
Cowan University, into chronic low back pain and malingering. The research itself is
being undertaken in association Brian Suter's clinic.

This research is not related to treatment in any way, and if you are still in treatment
then this research will have no bearing on your future treatment needs. The research
is interested in the methods that people with chronic lower back pain would use to
'pretend' that they have more pain than they really feel. In addition, it seeks to reduce
the conflict that often occurs between an insurance appointed assessor and chronic
pain patients in workers compensation claims. As all the participants will have
chronic low back pain there is a sense that they are the experts, and the researcher is
trying to learn from them. Basically you have been asked because, you are male, have
chronic low back pain, have previously attended Brian Suter's clinic and may or may
not have been involved in litigation.
Having indicated on the phone that you are willing to participate in the research you
will find enclosed a letter which asks you either to attempt to exaggerate how much
pain you feel or to give an accurate indication of your pain. It is important that you
understand that you will be designated either as an "exaggerating" or "accurate" pain
patient on a purely random basis and no prior testing or medical records have played a
part in this decision.
Also enclosed are five numeric rating scales for pain. You will be asked to fill these
out each day, for one week prior to going to the interview. The numeric rating scale
involves noting which number best represents your pain and is probably similar to
other pain measures you have completed.
Finally, as was indicated in the introductory phone caU, a twenty minute pain
evaluation will be conducted at a place most convenient to you. This may be your
home, Brian Suter's clinic or Edith Cowan University. This interview will be a
simulation of the sort of interview you would have to undergo for compensation. Your
daily pain rating scales and consent form will be coliected by the interviewer at the
conclusion of the interview.

When being interviewed you may use your own history or alter it slightly; provided
the basic facts and feelings surrounding your pain experience remain relatively
accurate as thls is major reason for the research. Whether or not you give an accurate
personal history, is largely irrelevant, as the focus on the research is how you depict
the issues involved. The results of the interview and the pain rating scales will be
stored in a locked cupboard in a security-coded room at the Edith Cowan University.

Once this study has enough participants the list containing the names and addresses
will be destroyed and only identification numbers will be used. Hence, the
participants in this study will be anonymous. The results of this research will only be
available to the researcher, David Curnow ( z"d Year Masters student) ana his
supervisor, Dr Irene Froyland. The results of this research may be published, at least
as a thesis, but in a form, where group results will be used making it impossible to

identify participants in the study. The processed data will also be available to
participants who ask for copies.

No individual data will be made available to the clinic or Brian Suter or any other
person or institution, unless there is a legal obligation to do so. However due to
certain procedural mechanisms it will very difficult to tell which responses were made
by a particular participant.

During the research you may withdraw at any time. You do not need to give any
explanation. If you do not wish to answer a question then you do not have to do so.
In addition, if you wish to ask questions, you may so at any time. It is important to
recognise that Brain Suter's clinic is not directly participating in this research, and it
is a researcher from Edith Cowan University that is completing the research.
If you are still involved in any legal action, or contemplate future legal action, in
regard to the incident related to your pain, you must preferably not participate in this
research project. If at any stage you need more information about the study you can
phone myself, or my supervisor, Dr Irene Froyland, on 9400-5415.
All participaots will be debriefed after the interview. Participants who have chosen to
withdraw from the study will be given the opportunity to be debriefed when they
withdraw.
If ao aspect of this interview disturb you then please contact Dr Irene Froy laod >.t
Edith Cowao University on 9400-5415 regarding your concerns. If there are
problems that arise during the interview, then Brian Suter will be available for
consultation.
When you have decided to be part of the research please detach the consent form
underneath and give it to the interviewer. These forms will be kept, but through the
use of code numbers as identification it will not be possible to identify the results of
individual participaots. If you have decided that you no longer wish to be part of this
study please ring David Curnow on 9400 5418 at the earliest possible time.
Thankyou for your support,

David Cumo'f

This will be collected at the time of the interview
!, _ _ _ _ _ _ _ _ __

(Please print)

*

have read and understood the consent form
' have had an opportunity to assess what is being asked of me
* have received adequate information
* can show that I understand the implications of this research
!, _ _ _ _ _ _ _ _ __

Sign: - - - - - - - - Witness:----------

(Please print) wish to participate in,this study.

Date: _ _ _ _ __
Date: _ _ _ _ __

I

APPENDIX M

Don't Forget your
Appointment
Remember that you have a
pain evaluation interview
for compensation on
____ at _ _ __

